<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/ProjectMundo/style/jats-html.xsl"?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-46116-y
   </article-id>
   <article-id pub-id-type="manuscript">
    46116
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-46116-y
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/499
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/575
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /141
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /38/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     Athari ya kubadilisha microbiome ya utumbo kwenye utendaji wa misuli na uelewa: jaribio la PROMOTe la udhibiti wa nasibu
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes" id="Au1">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5702-1759
     </contrib-id>
     <name name-style="western">
      <surname>
       Ni Lochlainn
      </surname>
      <given-names>
       Mary
      </given-names>
     </name>
     <address>
      <email>
       mary.ni_lochlainn@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor1">
      a
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6941-8160
     </contrib-id>
     <name name-style="western">
      <surname>
       Bowyer
      </surname>
      <given-names>
       Ruth C. E.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-3514-4528
     </contrib-id>
     <name name-style="western">
      <surname>
       Moll
      </surname>
      <given-names>
       Janne Marie
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       García
      </surname>
      <given-names>
       María Paz
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Wadge
      </surname>
      <given-names>
       Samuel
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Baleanu
      </surname>
      <given-names>
       Andrei-Florin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Nessa
      </surname>
      <given-names>
       Ayrun
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Sheedy
      </surname>
      <given-names>
       Alyce
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Akdag
      </surname>
      <given-names>
       Gulsah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-9066-4614
     </contrib-id>
     <name name-style="western">
      <surname>
       Hart
      </surname>
      <given-names>
       Deborah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-0925-4632
     </contrib-id>
     <name name-style="western">
      <surname>
       Raffaele
      </surname>
      <given-names>
       Giulia
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-7904-7933
     </contrib-id>
     <name name-style="western">
      <surname>
       Seed
      </surname>
      <given-names>
       Paul T.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Murphy
      </surname>
      <given-names>
       Caroline
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-8203-0769
     </contrib-id>
     <name name-style="western">
      <surname>
       Harridge
      </surname>
      <given-names>
       Stephen D. R.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6702-3704
     </contrib-id>
     <name name-style="western">
      <surname>
       Welch
      </surname>
      <given-names>
       Ailsa A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au16">
     <name name-style="western">
      <surname>
       Greig
      </surname>
      <given-names>
       Carolyn
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au17">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5414-2950
     </contrib-id>
     <name name-style="western">
      <surname>
       Whelan
      </surname>
      <given-names>
       Kevin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff12">
      12
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au18">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-4910-0489
     </contrib-id>
     <name name-style="western">
      <surname>
       Steves
      </surname>
      <given-names>
       Claire J.
      </given-names>
     </name>
     <address>
      <email>
       claire.j.steves@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor18">
      u
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London
      </institution>
      <institution content-type="org-name">
       Department of Twin Research and Genetic Epidemiology
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 7EH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/035dkdb55
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.499548.d
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 5903 3632
      </institution-id>
      <institution content-type="org-name">
       The Alan Turing Institute
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NW1 2DB
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00g934978
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.509919.d
      </institution-id>
      <institution content-type="org-name">
       Clinical Microbiomics
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Copenhagen
     </addr-line>
     <country country="DK">
      Denmark
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       GKT School of Medical Education
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Unit for Medical Statistics/Department for Women and Children’s Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s Clinical Trials Unit, Research Management and Innovation Directorate
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Centre for Human &amp; Applied Physiological Sciences
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/026k5mg93
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8273.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 1092 7967
      </institution-id>
      <institution content-type="org-division">
       Department of Epidemiology and Public Health, Norwich Medical School
      </institution>
      <institution content-type="org-name">
       University of East Anglia
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NR4 7TJ
     </addr-line>
     <addr-line content-type="city">
      Norwich
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/03angcq70
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.6572.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 1936 7486
      </institution-id>
      <institution content-type="org-division">
       School of Sport, Exercise, and Rehabilitation Sciences
      </institution>
      <institution content-type="org-name">
       University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution content-type="org-name">
       MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/014ja3n03
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.412563.7
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0376 6589
      </institution-id>
      <institution content-type="org-division">
       NIHR Birmingham Biomedical Research Centre
      </institution>
      <institution content-type="org-name">
       University Hospitals Birmingham NHS Foundation Trust and University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff12">
     <label>
      12
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London, Department of Nutritional Sciences
      </institution>
      <institution content-type="org-name">
       Franklin Wilkins Building
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 9NH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs4146702446116y_cor1">
     <label>
      a
     </label>
     <email>
      mary.ni_lochlainn@kcl.ac.uk
     </email>
    </corresp>
    <corresp id="IDs4146702446116y_cor18">
     <label>
      u
     </label>
     <email>
      claire.j.steves@kcl.ac.uk
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     29
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1859">
    1
   </issue>
   <elocation-id>
    1859
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      15
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      4
     </day>
     <month>
      8
     </month>
     <year>
      2023
     </year>
    </date>
    <date date-type="accepted">
     <day>
      12
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      29
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <pub-history>
    <event event-type="Correction">
     <event-desc>
      A Correction to this paper has been published: https://doi.org/10.1038/s41467-025-58771-w
     </event-desc>
     <date>
      <day>
       10
      </day>
      <month>
       4
      </month>
      <year>
       2025
      </year>
     </date>
    </event>
   </pub-history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-statement content-type="comment">
     corrected publication 2025
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <related-article ext-link-type="doi" related-article-type="correction-forward" xlink:href="10.1038/s41467-025-58771-w"/>
   <abstract id="Abs1" xml:lang="en">
    <title>
     Utangulizi
    </title>
    <p id="Par1">
     Masomo yanapendekeza kwamba kuleta mabadiliko ya microbiota ya utumbo yanaweza kubadilisha fiziolojia ya misuli na tabia ya kiakili. Microbiota ya utumbo inaweza kuchukua jukumu katika upinzani wa anaboliki wa misuli ya wazee, na uelewa. Katika jaribio hili la udhibiti wa kufanya majaribio ya kibinafsi na kufanya majaribio ya nasibu ya 36 jozi za watu wanaofanana (watu 72), waliokomaa zaidi ya miaka 60, kila jozi ya watu wanaofanana ilichaguliwa kwa nasibu kuwa na dawa ya kufanya majaribio au prebiotic kila siku kwa majuma 12. Mazoezi ya upinzani na nyongeza ya asidi ya mfuatano wa branched (BCAA) yalipendekezwa kwa washiriki wote. Matokeo ni utendaji wa kimwili na uelewa. Jaribio hili lilifanywa kwa njia ya mbali kwa kutumia ziara za video, maswali ya mtandaoni na majaribio ya kiakili, na kutuma vifaa na sampuli za kibaolojia. Nyongeza ya prebiotic ilikuwa imeridhika vyema na ilisababisha mabadiliko ya microbiome ya utumbo [kwa mfano, ongezeko la uwiano wa
     <italic>
      Bifidobacterium
     </italic>
     ]. Hakuna tofauti muhimu kati ya prebiotic na dawa ya kufanya majaribio kwa matokeo ya msingi ya muda wa kuinuka kwenye kiti (β = 0.579; 95% CI −1.080-2.239 p = 0.494). Prebiotic inaboresha uelewa (alama ya sababu dhidi ya dawa ya kufanya majaribio (β = −0.482; 95% CI,−0.813, −0.141; p = 0.014)). Matokeo yetu yanaonyesha kwamba uingiliaji kati wa microbiome ya utumbo ambao unapatikana kwa urahisi na unafaa unaweza kuboresha uelewa katika idadi yetu ya watu wazee. Tunapendekeza uwezekano wa majaribio yaliyotolewa kwa njia ya mbali kwa watu wazee, ambayo inaweza kupunguza uwakilishi mdogo wa watu wazee katika majaribio ya kimatibabu. Usajili wa ClinicalTrials.gov: NCT04309292.
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Here, the authors present the results of the PROMOTe trial, reporting improved cognition with prebiotic vs placebo in twins over 60 years old, probing that remote trials are feasible in older adults, and suggesting that the gut microbiota may represent a therapeutic target for age-associated morbidity.
    </p>
   </abstract>
   <kwd-group kwd-group-type="publisher-auto-generated" vocab="springer-nature-taxonomy" xml:lang="en">
    <kwd>
     Microbiome
    </kwd>
    <kwd>
     Nutritional Supplements
    </kwd>
    <kwd>
     Microbiota
    </kwd>
    <kwd>
     Cognitive ageing
    </kwd>
    <kwd>
     Placebo Effect
    </kwd>
    <kwd>
     Preclinical Research
    </kwd>
   </kwd-group>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1103">
      Clinical Sciences
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        DH | National Institute for Health Research (NIHR)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100000272
       </institution-id>
      </institution-wrap>
     </funding-source>
     <award-id award-type="FundRef grant">
      NIHR300159
     </award-id>
     <principal-award-recipient>
      <name name-style="western">
       <surname>
        Ni Lochlainn
       </surname>
       <given-names>
        Mary
       </given-names>
      </name>
     </principal-award-recipient>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      10926
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      2
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      15
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_46116.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-year
     </meta-name>
     <meta-value>
      2025
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-day
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      discipline
     </meta-name>
     <meta-value>
      Humanities and Social Sciences
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
  <notes notes-type="CrossLinking">
   <sec>
    <p>
     A correction to this article is available online at
     <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-025-58771-w">
      https://doi.org/10.1038/s41467-025-58771-w
     </ext-link>
     .
    </p>
   </sec>
  </notes>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    Utangulizi
   </title>
   <p id="Par3">
    Wastani wa umri wa idadi ya watu duniani unapoongezeka. Kama matokeo, maradhi yanayohusiana na umri na muda uliotumika kuishi na maradhi yanayohusiana na umri, ikijumuisha hasara ya misuli na kuzorota kwa akili, yanapoongezeka. Maradhi ya alzheimer yanayoongezeka duniani kote, lakini kama idadi ya watu inavyoongezeka umri, utambuzi wa mabadiliko ya akili ambayo yanaweza kutokea kama sehemu ya kuzeeka kwa afya itakuwa muhimu kwa watafiti na watoa huduma za afya wanaofanya kazi na watu wazee. Mazoezi yanaweza kupunguza hasara ya misuli na kuzorota kwa akili
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
    </sup>
    . Kuna sababu nyingi kwa nini watu wazee wanaweza kujitahidi kutekeleza mila za mazoezi, ambayo, kwa kuzingatia ufanisi wao uliopimwa wa kuboresha afya na utendaji, huwakilisha changamoto. Uingiliaji kati unaonyesha kwa uwazi unaotoa mchanganyiko mpana wa manufaa ya kimwili na ya kiakili ni muhimu.
   </p>
   <p id="Par4">
    Binadamu hupoteza misuli ya mifupa kwa kuongezeka kwa umri, na hali hiyo inaweza kusababisha sarcopenia. Protini ya chakula ni muhimu kwa ajili ya kudumisha afya ya misuli ya mifupa; hata hivyo, mambo kadhaa yanaweza kusababisha kupungua kwa kuchukua protini katika umri wa kuzeeka, ikijumuisha kutengwa kijamii, dysphagia, na uchukuaji wa chakula kwa utumbo ulio polepole
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Zaidi ya kula protini kidogo, utafiti umeonyesha kwamba watu wazee wanaonyesha upinzani wa kimetaboliki kwa kuchukua protini, utendakazi uliopunguzwa wa misuli ya wazee kwa mujibu wa usanisi wa protini wa misuli, ikilinganishwa na watu wachanga
    <sup>
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    . Hii imesababisha mapendekezo ya kuchukua protini kwa wingi wa 1-1.3 g/kg/siku kwa wataalamu, ikilinganishwa na Kipimo cha Chakula cha Marejeleo cha Uingereza kwa watu wazima wa 0.8 g/kg/siku
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    .
   </p>
   <p id="Par5">
    Mzigo wa misuli ya mifupa unasimamiwa na michakato ya usanisi wa protini ya misuli na kuharibika (MPS na MPB). Kiwango cha MPS kinatokana na utendakazi kwa vichochezi vya kimetaboliki, ikijumuisha ulaji wa chakula na shughuli za kimwili. Vichochezi vya kuharibu vikiwemo magonjwa, kutotumia nguvu, na ugonjwa, ambao watu wazee wana kiwango cha juu. Aetiology ya upinzani wa kimetaboliki ni changamano, ikijumuisha fiziolojia ya kuzeeka na kutotumia nguvu. Utafiti wa kuongeza protini kwa ajili ya utendaji wa misuli umeonyesha matokeo ya kuunga mkono zaidi wakati unapoambatana na mazoezi ya nguvu
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    . Mazoezi ya nguvu yamejikita kuwa na nguvu kubwa ya vichochezi vya kimetaboliki kwa misuli ya mifupa, na protini na mazoezi yanayoonyesha athari ya pamoja wakati zinapotumiwa pamoja
    <sup>
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     ,
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     ,
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
    </sup>
    .
   </p>
   <p id="Par6">
    Utafiti wa hivi punde unapendekeza kwamba utando wa mikojo unaweza kuwa muhimu kwa utendaji wa kiakili na kimwili katika kuzeeka. Utando wa mikojo unajumuisha bakteria, archaea, virusi, na viumbe vingine vya mikojo ambavyo huishi katika mikojo, jumla ya jeni zao na mazingira yanayozunguka. Jukumu lake katika kudumisha fiziolojia ya afya ni uwanja wa utafiti unaokua haraka. Kwa kuongezeka kwa umri, utulivu wa utando wa mikojo unapungua, kwani unakuwa hatarishi zaidi kwa magonjwa, dawa, na mabadiliko ya mtindo wa maisha, na mabadiliko ya utajiri wa spishi na kuongezeka kwa utofauti kati ya watu binafsi
    <sup>
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
     ,
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
     ,
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
    </sup>
    . Uwezo wa utando wa mikojo wa kubadilisha fiziolojia umeonyeshwa na utafiti wa kubadilishana mkojo wa wanyama ambao umeonyesha mabadiliko ya muundo wa mwili katika mwenyeji unaolingana na fenotaipe ya mtoa
    <sup>
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
    </sup>
    . Hii inaonyesha jukumu la mikojo katika kuchambua fenotaipe za kimetaboliki. Mbinu kadhaa zimependekezwa kwa upinzani wa kimetaboliki, na utando wa mikojo umezungumziwa kuwa na jukumu katika nyingi kati ya hizi
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     ,
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     ,
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     ,
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     ,
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    . Mifano ni pamoja na utengenezaji wa protini na usambarishaji, utendakazi wa kizuizi cha mkojo, na ugonjwa
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Zaidi ya hayo, kuna ushahidi kwamba utando wa mikojo unaweza kuathiri misuli ya mifupa kwa njia za kuharibu
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     ,
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    .
   </p>
   <p id="Par7">
    Vitamu vya chakula ni sehemu za chakula ambazo hutumika kwa utando wa mikojo kwa ajili ya kuboresha afya
    <sup>
     <xref ref-type="bibr" rid="CR24">
      24
     </xref>
    </sup>
    . Utoaji wa kiungo cha chakula cha prebiotic umeonyeshwa kuwa na athari ya kuboresha mbili kati ya vipimo vya Fried vya ulemavu, hasa nguvu ya kushikamana na uchovu na kiwango cha jumla cha ulemavu, kwa watu wazee. Zaidi ya hayo, ushahidi unaoongezeka unapendekeza kuwepo kwa shoka ya mkojo-akili, ikijumuisha ushahidi wa awali wa athari ya manufaa ya kuongeza prebiotic kwenye akili
    <sup>
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
    </sup>
    . Kwa hivyo, mikojo inaweza kuwakilisha lengo la matibabu linaloweza kubadilishwa kwa ajili ya kuzuia na kugeuza hasara ya misuli kwa umri na kuzorota kwa akili kwa umri. Hakuna utafiti uliopita ambao umechunguza athari za kiungo kinachojumuisha protini na prebiotics kwenye utendaji wa kimwili na kiakili kwa watu wazee. Mambo ya kijeni na kimazingira yanaweza kuathiri utendaji wa kimwili na kiakili, na kuchukua kwa nasibu ndani ya jozi za watu wanaofanana huondoa tofauti inayohusishwa na mambo yaliyoshirikiwa, na kuwezesha utafiti wenye nguvu zaidi. Kwa ujuzi wetu, hakuna utafiti mwingine ambao umechunguza athari za viungo vya protini na prebiotics katika idadi ya watu wanaofanana.
   </p>
   <p id="Par8">
    Swali hili linalenga kutathmini kama kubadilisha utumbo wa microbiome kwa kutumia prebiotic huimarisha utendaji wa misuli (kama ilivyo kuhesabiwa na 5 × wakati wa kuinuka kwenye kiti, alama ya nguvu ya misuli) ikilinganishwa na dawa ya kufikia katika jaribio ambapo washiriki wote wanapata protini (asidi za amino za branched chain [BCAA]) na mazoezi ya upinzani. Swali hili lilikuwa limeundwa ili kujaribu kama kuongeza kubadilisha utumbo wa microbiome kunaweza kuongeza uboreshaji wa utendaji wa misuli uliowekwa kutoka kwa BCAA na mazoezi iliyounganishwa. Matokeo ya pili yalikuwa uelewa, nguvu ya kugonga, batili ya utendaji wa kimwili mfupi, hamu ya chakula, na hatua za microbiome ya utumbo. Matumizi ya twins, ambao wanafanana kwa karibu kwa sababu za kijeni na kimazingira, yalimimarisha muundo wa swali.
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    Matokeo
   </title>
   <p id="Par9">
    Jumla ya watu 626 walitathminiwi kwa ajili ya kufaa, kati yao 72 waliofanikiwa kuajiriwa (jozi 36 za twins). Fig
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    inaonyesha mtiririko wa washiriki kupitia swali. Uajiri ulifunguliwa mnamo Mei 2021. Tarehe ya ziara ya kwanza kwa mshiriki wa kwanza ilikuwa 17/05/2021, na tarehe ya ziara ya pili (ya mwisho) ya mshiriki wa mwisho ilikuwa 20/12/2021. Jedwali
    <xref ref-type="table" rid="Tab1">
     1
    </xref>
    lina sifa za msingi za washiriki wa swali. Washiriki walikuwa na umri wa wastani wa 73 (anuwai 63–83) na walikuwa 78% wa kike (56/72). Mikono ilikuwa ililingana vizuri katika msingi, kama ilivyo tarajiwa, kwa kuwa jozi za twins zilikuwa zimeundwa. Hata hivyo, kulikuwa na tofauti kati ya makundi mawili kwa alama ya hamu ya chakula ya SNAQ. Kwa hiyo, hii ilijumuisha katika uchambuzi unaofuata kama mchangiaji wa uwezekano. Hamu ya chakula ilijumuisha katika swali kwa sababu tunajua muundo wa microbiome ya utumbo na kuchukua protini vinavyoathiriwa na hamu ya chakula
    <sup>
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    .
    <fig id="Fig1" position="float">
     <label>
      Fig. 1
     </label>
     <caption xml:lang="sw">
      <title>
       Mchoro wa mtiririko wa washiriki.
      </title>
      <p>
       Mtiririko wa washiriki kupitia jaribio, ikijumuisha tathmini ya uwezo wa kuingia, usambazaji wa nasibu, kufuatilia na uchambuzi.
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
    <table-wrap id="Tab1">
     <label>
      Table 1
     </label>
     <caption xml:lang="en">
      <p>
       Maelezo ya Msingi, kwa kundi la utafiti
      </p>
     </caption>
     <table frame="hsides" rules="groups">
      <thead>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          Jumla
         </p>
        </th>
        <th>
         <p>
          Prebiotic
         </p>
        </th>
        <th>
         <p>
          Placebo
         </p>
        </th>
        <th>
         <p>
          <italic>
           p
          </italic>
          -Thamani
         </p>
        </th>
       </tr>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 72
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th/>
       </tr>
      </thead>
      <tbody>
       <tr>
        <td>
         <p>
          Umri (miaka)
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.1 (4.8)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Jinsia
         </p>
        </td>
        <td>
         <p>
          Mwanamke
         </p>
        </td>
        <td>
         <p>
          56 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mwanaume
         </p>
        </td>
        <td>
         <p>
          16 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Zygosity
         </p>
        </td>
        <td>
         <p>
          Monozygotic
         </p>
        </td>
        <td>
         <p>
          44 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Dizygotic
         </p>
        </td>
        <td>
         <p>
          28 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Hadhi ya Kuvuta Sigara
         </p>
        </td>
        <td>
         <p>
          Hajavuti Sigara
         </p>
        </td>
        <td>
         <p>
          38 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          0.570
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Aliyeacha Kuvuta Sigara
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Anavyuvuta Sigara
         </p>
        </td>
        <td>
         <p>
          4 (5.6%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Mapato ya Kaya
         </p>
        </td>
        <td>
         <p>
          Kataa kujibu
         </p>
        </td>
        <td>
         <p>
          13 (18.1%)
         </p>
        </td>
        <td>
         <p>
          5 (13.9%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.590
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Chini
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Kati
         </p>
        </td>
        <td>
         <p>
          23 (31.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          9 (25.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Juu
         </p>
        </td>
        <td>
         <p>
          6 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Kiwango cha Elimu
         </p>
        </td>
        <td>
         <p>
          Chini
         </p>
        </td>
        <td>
         <p>
          33 (45.8%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td>
         <p>
          15 (41.7%)
         </p>
        </td>
        <td>
         <p>
          0.730
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Kati
         </p>
        </td>
        <td>
         <p>
          25 (34.7%)
         </p>
        </td>
        <td>
         <p>
          11 (30.6%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Juu
         </p>
        </td>
        <td>
         <p>
          14 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Unyweo wa Pombe
         </p>
        </td>
        <td>
         <p>
          Hajanywea Pombe
         </p>
        </td>
        <td>
         <p>
          20 (27.8%)
         </p>
        </td>
        <td>
         <p>
          12 (33.3%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.510
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Chini ya Kila Wiki
         </p>
        </td>
        <td>
         <p>
          17 (23.6%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          10 (27.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Angalau Kila Wiki
         </p>
        </td>
        <td>
         <p>
          35 (48.6%)
         </p>
        </td>
        <td>
         <p>
          17 (47.2%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Uzito (kg)
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.8 (15.7)
         </p>
        </td>
        <td>
         <p>
          71.8 (14.0)
         </p>
        </td>
        <td>
         <p>
          75.8 (17.2)
         </p>
        </td>
        <td>
         <p>
          0.280
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Urefu (m)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.950
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Ukubwa wa Mwili
         </p>
        </td>
        <td/>
        <td>
         <p>
          28.0 (5.1)
         </p>
        </td>
        <td>
         <p>
          27.3 (5.0)
         </p>
        </td>
        <td>
         <p>
          28.7 (5.3)
         </p>
        </td>
        <td>
         <p>
          0.240
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Chakula cha Mafuta (g/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          60.7 (14.4)
         </p>
        </td>
        <td>
         <p>
          60.1 (16.2)
         </p>
        </td>
        <td>
         <p>
          61.3 (12.5)
         </p>
        </td>
        <td>
         <p>
          0.710
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Mafuta/Mwili (g/kg/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.8 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.910
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Nishati (kcals/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1569.5 (397.7)
         </p>
        </td>
        <td>
         <p>
          1581.6 (380.5)
         </p>
        </td>
        <td>
         <p>
          1557.5 (419.2)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Ukubwa wa Ulemavu
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.790
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kasi ya Kuhama (m/s)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.3)
         </p>
        </td>
        <td>
         <p>
          0.640
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Muda wa Kukaa (s)
         </p>
        </td>
        <td/>
        <td>
         <p>
          10.6 (3.3)
         </p>
        </td>
        <td>
         <p>
          10.3 (3.2)
         </p>
        </td>
        <td>
         <p>
          11.0 (3.5)
         </p>
        </td>
        <td>
         <p>
          0.370
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Nguvu ya Mkono (kg)
         </p>
        </td>
        <td/>
        <td>
         <p>
          26.0 (9.7)
         </p>
        </td>
        <td>
         <p>
          25.7 (9.5)
         </p>
        </td>
        <td>
         <p>
          26.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya Usawa
         </p>
        </td>
        <td/>
        <td>
         <p>
          4.0 (0.2)
         </p>
        </td>
        <td>
         <p>
          4.0 (0.0)
         </p>
        </td>
        <td>
         <p>
          3.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya Uwezo wa Kimwili
         </p>
        </td>
        <td/>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          10.9 (1.5)
         </p>
        </td>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          0.810
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          IPAQ MET dakika/ wiki
         </p>
        </td>
        <td/>
        <td>
         <p>
          674.8 (654.5)
         </p>
        </td>
        <td>
         <p>
          564.8 (591.2)
         </p>
        </td>
        <td>
         <p>
          784.8 (703.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya IPAQ
         </p>
        </td>
        <td>
         <p>
          Shughuli za Chini
         </p>
        </td>
        <td>
         <p>
          69 (95.8%)
         </p>
        </td>
        <td>
         <p>
          35 (97.2%)
         </p>
        </td>
        <td>
         <p>
          34 (94.4%)
         </p>
        </td>
        <td>
         <p>
          0.560
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Shughuli za Kati
         </p>
        </td>
        <td>
         <p>
          3 (4.2%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td>
         <p>
          2 (5.6%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Hamu ya Chakula—SNAQ
         </p>
        </td>
        <td/>
        <td>
         <p>
          15.2 (2.0)
         </p>
        </td>
        <td>
         <p>
          14.7 (2.0)
         </p>
        </td>
        <td>
         <p>
          15.8 (1.9)
         </p>
        </td>
        <td>
         <p>
          0.046*
         </p>
        </td>
       </tr>
       <tr>
        <td colspan="6">
         <p>
          Ufahamu (CANTAB)
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="2">
         <p>
          Kazi ya Kufikiri
         </p>
        </td>
        <td>
         <p>
          OTS—muda wa jibu (kasi ya jibu; ms)
         </p>
        </td>
        <td>
         <p>
          32773.2 (20028.7)
         </p>
        </td>
        <td>
         <p>
          37476.2 (24711.6)
         </p>
        </td>
        <td>
         <p>
          28766.9 (14250.0)
         </p>
        </td>
        <td>
         <p>
          0.130
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Matatizo ya Kufikiri (idadi ya makosa)
         </p>
        </td>
        <td>
         <p>
          14.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          13.0 (8.7)
         </p>
        </td>
        <td>
         <p>
          15.3 (11.0)
         </p>
        </td>
        <td>
         <p>
          0.420
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="4">
         <p>
          Ukumbukumbu
         </p>
        </td>
        <td>
         <p>
          PAL: alama ya kumbukumbu ya kwanza
         </p>
        </td>
        <td>
         <p>
          11.9 (4.6)
         </p>
        </td>
        <td>
         <p>
          12.5 (4.5)
         </p>
        </td>
        <td>
         <p>
          11.4 (4.7)
         </p>
        </td>
        <td>
         <p>
          0.430
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          PAL: jumla ya idadi ya makosa
         </p>
        </td>
        <td>
         <p>
          18.0 (16.2)
         </p>
        </td>
        <td>
         <p>
          16.7 (15.9)
         </p>
        </td>
        <td>
         <p>
          19.2 (16.7)
         </p>
        </td>
        <td>
         <p>
          0.580
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Ukumbukumbu wa Kutambua (asilimia sahihi)
         </p>
        </td>
        <td>
         <p>
          89.5 (10.5)
         </p>
        </td>
        <td>
         <p>
          87.0 (11.7)
         </p>
        </td>
        <td>
         <p>
          91.7 (9.0)
         </p>
        </td>
        <td>
         <p>
          0.110
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Urefu wa Kumbukumbu (urefu wa mstari mbele; safu 2-9)
         </p>
        </td>
        <td>
         <p>
          5.7 (1.3)
         </p>
        </td>
        <td>
         <p>
          5.9 (1.6)
         </p>
        </td>
        <td>
         <p>
          5.5 (1.0)
         </p>
        </td>
        <td>
         <p>
          0.350
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Data ya Ufahamu iliyokosekana
         </p>
        </td>
        <td>
         <p>
          22
         </p>
        </td>
        <td>
         <p>
          13
         </p>
        </td>
        <td>
         <p>
          9
         </p>
        </td>
        <td/>
       </tr>
      </tbody>
     </table>
     <table-wrap-foot>
      <p>
       Data ya mara kwa mara imetolewa kama wastani (kipunguzo cha kawaida). Data ya aina nyingine imetolewa kama
       <italic>
        n
       </italic>
       (%). * Inaashiria umuhimu. Idadi ya data iliyokosekana imetolewa kwa ufahamu; vigeu vingine havina data iliyokosekana.
       <italic>
        P
       </italic>
       maadili ni mlinganyo wa kundi kati ya kila kundi la utafiti uliofanywa kwa kutumia
       <italic>
        t
       </italic>
       -jaribio la pande mbili.
      </p>
      <p>
       <italic>
        SPPB
       </italic>
       utendaji mfupi wa kimwili,
       <italic>
        IPAQ
       </italic>
       swali la shughuli za kimwili za kimataifa,
       <italic>
        MET
       </italic>
       sawa na nishati ya mwili (Moja MET ni nishati unayotumia wakati wa kupumzika),
       <italic>
        SNAQ
       </italic>
       swali la utathmini rahisi wa lishe,
       <italic>
        CANTAB
       </italic>
       jaribio la kimwili la Cambridge lililokamilishwa kwa kompyuta,
       <italic>
        OTS
       </italic>
       jaribio la kumbukumbu la Cambridge,
       <italic>
        PAL
       </italic>
       mchakato wa kufikiri.
      </p>
     </table-wrap-foot>
    </table-wrap>
   </p>
   <p id="Par10">
    Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S4
    </xref>
    linaonyesha data ya lishe iliyorekodiwa na washiriki katika msingi wa swali na mwisho wa swali kwa kutumia programu ya mtandaoni ya myfood24. Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S5
    </xref>
    linaonyesha data sawa na wale wanaoripoti zaidi wametolewa kutoka kwa uchanganuzi. Hakuna wale walioripotiwa kidogo waliambatishwa. Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    linaonyesha data ya lishe kwa kundi la swali. Hakukuwa na tofauti kati ya vikundi vya prebiotic na dawa ya kufikia katika msingi au katika mwisho wa swali kwa vipimo vyovyote vya kuchukua nyuzi. Kwa ujumla, kulikuwa na kupungua kidogo kwa kuchukua nishati kati ya msingi na mwisho wa swali, ambayo inaonekana kuwa imeendeshwa na kupungua kwa kundi la prebiotic (−132.4 kcal/d). Tofauti hii ndogo kati ya vikundi vya prebiotic na dawa ya kufikia (75.6 kcal/d) inaanguka ndani ya mipaka ya makosa ya kupima kuchukua nishati. Athari ya kupungua kwa kuchukua nishati hii kujumlisha kwa wakati, inayoweza kuwa na uwezo wa kufanya kazi kupitia athari ya inulin kwenye hamu ya chakula, inaweza kuchangia athari kwenye nguvu ya misuli. Hata hivyo, tunafahamu vikwazo vya kuweza kupima mabadiliko madogo kama hayo katika kuchukua nishati hata tunapotumia mbinu za kurekodi lishe za hali ya juu katika watu wanaoishi kwa uhuru. Hakukuwa na tofauti za maana kati ya uzito wa mwili (kg) au index ya uzito wa mwili kati ya msingi na mwisho wa swali katika mikono yoyote (Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    )
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
     ,
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
    </sup>
    .
   </p>
   <p id="Par11">
    Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S7
    </xref>
    linaonyesha matokeo ya swali la desturi za kuharisha, bila kupatikana tofauti kati ya vikundi vya utatili kwa swali lolote linalohusiana na desturi za kuharisha. Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    linaonyesha sifa za kijamii za wale waliozuiliwa au waliozuia kushiriki dhidi ya wale waliojumuika, kwa kutumia data ya muda mrefu ya TwinsUK. Kikundi hiki kina wengi wa kike kwa sababu za kihistoria. Washiriki walikuwa vijana zaidi na kulikuwa na wanaume zaidi kuliko kikundi kikubwa cha TwinsUK. Tofauti ya maana ilibaki baada ya kurekebisha tofauti ya jinsia kwa umri na tofauti ya umri kwa jinsia (Jedwali la ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    ).
   </p>
   <sec id="Sec3">
    <title>
     Matukio mabaya na utiifu
    </title>
    <p id="Par12">
     Kulikuwa na wingi wa matukio ya hatari kidogo (kama vile kujaa kwenye tumbo) katika mkono wa prebiotic kuliko mkono wa dawa ya kufikia, lakini hakukuwa na tofauti katika kufuata, ikionyesha kuwa viungio hivi vilikuwa vizuri vinavyostahimiliwa. Hakuna mshiriki aliyesema kuwa ‘athari za upande wa utumbo’ kama sababu ya kutofuata mpango wa utatili katika mikono yoyote. Hakuna matukio ya hatari makubwa yaliyotokea.
    </p>
    <p id="Par13">
     Jedwali la
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     linaonyesha idadi ya matukio mabaya kwa kila mkono na utiifu wa majaribio. Jedwali la ziada la
     <xref ref-type="supplementary-material" rid="MOESM1">
      S2
     </xref>
     linaorodhesha matukio yote mabaya yaliyoripotiwa na washiriki. Pia tulirekodi mabadiliko ya dawa (Jedwali la
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ) wakati wa masomo, ambayo yalikuwa chache kwa kiasi.
     <table-wrap id="Tab2">
      <label>
       Table 2
      </label>
      <caption xml:lang="en">
       <p>
        Matukio mabaya ya PROMOTe, mabadiliko ya dawa, utiifu, na kuachana na utafiti kwa kundi la utafiti
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           Jumla
          </p>
         </th>
         <th>
          <p>
           Kundi la Prebiotic
          </p>
         </th>
         <th>
          <p>
           Kundi la Placebo
          </p>
         </th>
         <th>
          <p>
           <italic>
            p
           </italic>
           -Thamani
          </p>
         </th>
        </tr>
        <tr>
         <th/>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 72
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th/>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td>
          <p>
           Kuacha utafiti
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           4 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           1
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tukio la kutokuwa na tamaa
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           10 (7%)
          </p>
         </td>
         <td>
          <p>
           8 (22%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           0.041*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko ya dawa
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           7/60 (12%)
          </p>
         </td>
         <td>
          <p>
           2/29 (7%)
          </p>
         </td>
         <td>
          <p>
           5/31 (16%)
          </p>
         </td>
         <td>
          <p>
           0.270
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           <italic>
            Utiifu
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Shughuli za kimwili
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           28/29 (97%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Sacheti
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           29/29 (100%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Idadi ya sacheti, % ya utiifu wastani (SD)
          </p>
         </td>
         <td>
          <p>
           78.7% (9.6)
          </p>
         </td>
         <td>
          <p>
           79.7% (10.5)
          </p>
         </td>
         <td>
          <p>
           77.5% (8.6)
          </p>
         </td>
         <td>
          <p>
           0.370
          </p>
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Data imetolewa kama
        <italic>
         n
        </italic>
        (%). Kwa data yenye data isiyo kamili inayopatikana, data imetolewa kama
        <italic>
         n
        </italic>
        /
        <italic>
         N
        </italic>
        (%).
        <italic>
         P
        </italic>
        maadili ni mlinganyo wa kundi kati ya kila kundi la utafiti uliofanywa kwa kutumia
        <italic>
         t
        </italic>
        -jaribio la pande mbili. * inaashiria umuhimu.
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     Matokeo ya msingi na ya pili
    </title>
    <p id="Par14">
     Matokeo ya miundo ya mseto ya mstari kwa matokeo ya msingi na ya pili yanapatikana kwenye Jedwali la
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     , ikijumuisha uchambuzi wa matibabu ya nia (ITT) na kwa kufuata itifaki (PP). Hakukuwa na tofauti za kubwa katika matokeo kati ya miundo ya ITT na PP. Hakukuwa na tofauti kati ya prebiotic na placebo kwa matokeo ya msingi ya muda wa kuinuka kwenye kiti (mabadiliko ya wastani kati ya awali na mwisho wa masomo 0.88 s [SD 2.16] kwa prebiotic na 1.12 s [SD 1.52] kwa placebo;
     <italic>
      p
     </italic>
     = 0.631), wala kwa matokeo ya pili ya utendaji wa kimwili (nguvu ya kushika, batiri fupi ya utendaji wa kimwili, na IPAQ MET dakika) au alama ya SNAQ ya hamu.
     <table-wrap id="Tab3">
      <label>
       Table 3
      </label>
      <caption xml:lang="en">
       <p>
        Matokeo ya muundo wa mchanganyiko wa mstari kwa matokeo ya msingi na ya pili
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th colspan="2">
          <p>
           Matokeo
          </p>
         </th>
         <th>
          <p>
           Prebiotic
          </p>
         </th>
         <th>
          <p>
           Placebo
          </p>
         </th>
         <th colspan="6">
          <p>
           Athari ya matibabu (prebiotic = kundi la kawaida)
          </p>
         </th>
        </tr>
        <tr>
         <th colspan="2"/>
         <th/>
         <th/>
         <th colspan="3">
          <p>
           Uchambuzi wa nia ya kufanya
          </p>
         </th>
         <th colspan="3">
          <p>
           Uchambuzi wa kufuata kanuni
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            Matokeo ya msingi
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           Mgawo
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            P
           </italic>
           -thamani
          </p>
         </td>
         <td>
          <p>
           Mgawo
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            P
           </italic>
           -thamani
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Muda wa kukaa (sekunde)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           10.38 (3.21)
          </p>
         </td>
         <td>
          <p>
           10.24 (2.21)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           9.49 (2.89)
          </p>
         </td>
         <td>
          <p>
           9.12 (1.96)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.88 (2.16)
          </p>
         </td>
         <td>
          <p>
           1.12 (1.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            Matokeo ya pili
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Nguvu ya mkono (kg)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           26.23 (9.33)
          </p>
         </td>
         <td>
          <p>
           25.52 (9.27)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           28.98 (11.64)
          </p>
         </td>
         <td>
          <p>
           29.14 (10.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           2.74 (10.76)
          </p>
         </td>
         <td>
          <p>
           3.45 (8.48)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Alama ya utendaji mfupi wa kimwili (safu 0-12)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           10.88 (1.49)
          </p>
         </td>
         <td>
          <p>
           11.32 (1.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           11.12 (1.32)
          </p>
         </td>
         <td>
          <p>
           11.45 (0.81)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.24 (1.05)
          </p>
         </td>
         <td>
          <p>
           0.06 (1.01)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           IPAQ MET dakika
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           194.43
          </p>
         </td>
         <td>
          <p>
           −111.39, 500.24
          </p>
         </td>
         <td>
          <p>
           0.213
          </p>
         </td>
         <td>
          <p>
           245.18
          </p>
         </td>
         <td>
          <p>
           −70.36, 560.73
          </p>
         </td>
         <td>
          <p>
           0.128
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           538.09 (596.87)
          </p>
         </td>
         <td>
          <p>
           769.30 (640.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           771.09 (594.28)
          </p>
         </td>
         <td>
          <p>
           1030.83 (648.33)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           256.06 (853.84)
          </p>
         </td>
         <td>
          <p>
           72.04 (866.41)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Hamu ya chakula (SNAQ) (safu 4-20)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.19
          </p>
         </td>
         <td>
          <p>
           −0.54,0.92
          </p>
         </td>
         <td>
          <p>
           0.607
          </p>
         </td>
         <td>
          <p>
           0.24
          </p>
         </td>
         <td>
          <p>
           −0.51,0.99
          </p>
         </td>
         <td>
          <p>
           0.532
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           14.79 (1.79)
          </p>
         </td>
         <td>
          <p>
           15.89 (1.76)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           14.71 (1.88)
          </p>
         </td>
         <td>
          <p>
           15.80 (2.00)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.29)
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.62)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="4">
          <p>
           Ufahamu (CANTAB)
          </p>
         </td>
         <td>
          <p>
           Alama ya ufahamu
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           0.05 (1.00)
          </p>
         </td>
         <td>
          <p>
           −0.23 (0.94)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.59 (0.68)
          </p>
         </td>
         <td>
          <p>
           0.18 (0.60)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.40 (0.83)
          </p>
         </td>
         <td>
          <p>
           0.19 (0.70)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="8">
          <p>
           Kazi ya kufikiri
          </p>
         </td>
         <td>
          <p>
           OTS—muda wa jibu (kasi ya jibu; ms)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           37,837.29 (25230.98)
          </p>
         </td>
         <td>
          <p>
           28,318.90 (14707.45)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           32,737.31 (21417.24)
          </p>
         </td>
         <td>
          <p>
           26,555.30 (13306.24)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −1.0e + 04 (13,978.77)
          </p>
         </td>
         <td>
          <p>
           −6594.90 (9405.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Matatizo ya kufikiri (idadi ya makosa)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           12.77 (8.89)
          </p>
         </td>
         <td>
          <p>
           15.13 (11.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           10.15 (6.39)
          </p>
         </td>
         <td>
          <p>
           11.23 (9.16)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −3.08 (9.22)
          </p>
         </td>
         <td>
          <p>
           −5.46 (10.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="16">
          <p>
           Ukumbukumbu
          </p>
         </td>
         <td>
          <p>
           PAL: alama ya kumbukumbu ya kwanza
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           12.41 (4.64)
          </p>
         </td>
         <td>
          <p>
           10.88 (4.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           14.54 (3.99)
          </p>
         </td>
         <td>
          <p>
           12.69 (3.38)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           1.77 (4.53)
          </p>
         </td>
         <td>
          <p>
           0.77 (4.19)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           PAL: jumla ya idadi ya makosa
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           17.05 (16.13)
          </p>
         </td>
         <td>
          <p>
           20.67 (17.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           9.15 (7.05)
          </p>
         </td>
         <td>
          <p>
           12.23 (10.15)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −5.15 (13.92)
          </p>
         </td>
         <td>
          <p>
           −5.00 (12.34)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Ukumbukumbu wa kutambua (% sahihi)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           86.74 (11.97)
          </p>
         </td>
         <td>
          <p>
           91.32 (9.35)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           97.44 (7.12)
          </p>
         </td>
         <td>
          <p>
           93.59 (7.72)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           8.33 (7.61)
          </p>
         </td>
         <td>
          <p>
           1.92 (9.71)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Urefu wa kumbukumbu (urefu wa mstari mbele; safu 2–9)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           5.91 (1.63)
          </p>
         </td>
         <td>
          <p>
           5.50 (1.06)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           6.69 (1.60)
          </p>
         </td>
         <td>
          <p>
           5.46 (0.66)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.54 (1.56)
          </p>
         </td>
         <td>
          <p>
           −0.23 (1.09)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Kundi la prebiotic ni kundi la kawaida * Inaashiria umuhimu.
       </p>
       <p>
        Data ya mara kwa mara imetolewa kama wastani (kipunguzo cha kawaida), na data nyingine imetolewa kama
        <italic>
         n
        </italic>
        (%). Mfano wa mstari wa mchanganyiko wote umesawazishwa kwa alama ya SNAQ katika msingi.
       </p>
       <p>
        <italic>
         CI
        </italic>
        uwezo wa kujiamini,
        <italic>
         SPPB
        </italic>
        utendaji mfupi wa kimwili,
        <italic>
         IPAQ
        </italic>
        swali la shughuli za kimwili za kimataifa,
        <italic>
         MET
        </italic>
        sawa na nishati ya mwili (Moja MET ni nishati unayotumia wakati wa kupumzika),
        <italic>
         SNAQ
        </italic>
        swali la utathmini rahisi wa lishe,
        <italic>
         CANTAB
        </italic>
        jaribio la kimwili la Cambridge lililokamilishwa kwa kompyuta,
        <italic>
         OTS
        </italic>
        jaribio la kumbukumbu la Cambridge,
        <italic>
         PAL
        </italic>
        mchakato wa kufikiri.
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
    <p id="Par15">
     Kundi la prebiotic lilionyesha kuboreshwa kwa kiasi kikubwa katika alama ya kwanza ya kiakili ikilinganishwa na placebo (
     <italic>
      β
     </italic>
     = −0.482; 95% CI −0.813, −0.141;
     <italic>
      p
     </italic>
     = 0.014). Kwa kuongeza, jaribio maalum la kiakili la kujifunza kwa jozi (jaribio la kumbukumbu) lilikuwa na idadi ya makosa chini katika kundi la prebiotic ikilinganishwa na kundi la placebo (
     <italic>
      β
     </italic>
     = 7.55; 95% CI: 4.65–10.46;
     <italic>
      p
     </italic>
     = 0.001). Jaribio hili maalum la kiakili lina umuhimu wa kimatibabu, kwani limeainishwa kama kielelezo cha mapema cha ugonjwa wa Alzheimer
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     . Upotevu wa data ulikuwa wa juu zaidi kwa majaribio ya kiakili ya CANTAB ikilinganishwa na vigeu vingine vya matokeo. Hakuna tofauti za kimaadili zilizopatikana wakati wa kulinganisha sifa za kidemografia za wale waliofanya majaribio ya kiakili na wale ambao hawakufanya, kwa hivyo hakuna sifa mahususi zinazotabiri upotevu wa majaribio ya kiakili, kama inavyoonyeshwa kwenye Jedwali la ziada la
     <xref ref-type="supplementary-material" rid="MOESM1">
      S3
     </xref>
     <sup/>
     . Hakuna uchambuzi usiopangwa wa post-hoc uliofanywa.
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     Matokeo ya microbiota ya utumbo
    </title>
    <p id="Par16">
     Kwa kuongeza kwa matokeo ya pili ya utendaji wa kimwili, muundo na utendakazi wa mikrobiomu ya utumbo ulichambuliwa na kupatikana kutoka kwa sampuli za mkojo. Data nzuri za kuainisha ulipatikana kutoka kwa sampuli zote, na wastani wa jozi 21.6 M za kusoma kwa kila sampuli na kiwango cha chini cha jozi 11.7 M. (Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S1
     </xref>
     ). Kwa wastani, jozi 17.9 M za kusoma kwa kila sampuli zilikuwa zinaweza kuunganishwa kwenye katalogi ya jeni, ikionyesha kwa wastani 82.8% ya maandishi ya HQNH (min = 68.5%, tazama Jedwali la ziada la
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ), ikionyesha 1494 MGS. Sampuli nyingi zilikuwa zinadominwa na familia
     <italic>
      Bacteroidaceae
     </italic>
     ,
     <italic>
      Oscillospiraceae
     </italic>
     , na
     <italic>
      Lachnospiraceae
     </italic>
     , na kuwa na tofauti fulani za kati ya mtu binafsi, kama ilivyoletwa.
    </p>
    <sec id="Sec6">
     <title>
      Ufanano wa microbiota kati ya jozi za watu wanaofanana
     </title>
     <p id="Par17">
      Ufanano kati ya muundo wa mikrobiomu ya utumbo wa jozi za masomo kwa awali na mwisho wa masomo ulichunguzwa, na uchambuzi wa urithi ulifanywa (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S2
      </xref>
      ). Wakati kulikuwa na ushahidi wa tofauti za ndani za jozi za mikrobiomu ya utumbo (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S3
      </xref>
      ), tulipata kwamba mikrobiomu ya jozi za utumbo ilikuwa na ufanano mkubwa zaidi ikilinganishwa na muundo wa mikrobiomu ya watu wasio wanafamilia wala wanaoana, wakati wa awali (
      <italic>
       U
      </italic>
      = 55579,
      <italic>
       p
      </italic>
      = 0.0026) na mwisho wa masomo (
      <italic>
       U
      </italic>
      = 44342,
      <italic>
       p
      </italic>
      = 0.00072), kwa kutumia tofauti ya Bray-Curtis (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S4
      </xref>
      ).
     </p>
     <p id="Par18">
      Ingawa thamani za p za jaribio la Mann–Whitney
      <italic>
       U
      </italic>
      zinazolinganisha jozi za watu wanaoziungana na wasio wanaoziungana ni muhimu katika vipindi vyote viwili, uchambuzi wa kiufasiri wa kihesabu ulifanywa ili kuthibitisha kwamba matokeo haya hayakusababishwa na idadi kubwa ya uchunguzi kati ya watu wasio wanaoziungana. Kwa kulinganisha jozi 35 za watu wanaoziungana, kuna uchunguzi mengi zaidi kati ya watu wasio wanaoziungana (35 * (35 − 1)/2 = 595 uchunguzi) kuliko jozi mbili za watu wanaoziungana (uchunguzi 35), ambayo inaharibu uhalali wa mlinganyo wa kimahesabu wa kulinganisha vikundi viwili kwa sababu ya idadi kubwa ya uchunguzi katika kundi la wasio wanaoziungana. Kwa hiyo, mbinu ya kubadilisha ilitumika ili kuthibitisha ikiwa thamani ya jaribio iliyopatikana kwa kulinganisha vikundi ilikuwa tofauti kwa kiwango cha kimaadili kutoka kwa usambazaji wa thamani ya jaribio uliopatikana kwa kubadilisha kwa nasibu lebo za uchunguzi (Fig. ya Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S5
      </xref>
      ). Kwa vipindi vyote viwili vya msingi na mwisho wa masomo, thamani ya
      <italic>
       p
      </italic>
      ya mlinganisho kati ya thamani ya jaribio halisi na usambazaji wa thamani ya jaribio uliopatikana kutoka kwa mabadiliko yalikuwa karibu na sifuri (jaribio la Mann–Whitney
      <italic>
       U
      </italic>
      ,
      <italic>
       P
      </italic>
      = 3.33 * 10 na 3.33 * 10, kwa msingi na mwisho wa masomo, kwa mtiririko huo), ikionyesha kwamba muundo wa vijidudu vya utumbo ni zaidi sawa ndani ya jozi za watu wanaoziungana kuliko kati ya watu wawili kutoka kwa jozi tofauti za watu wanaoziungana
      <sup/>
      .
     </p>
    </sec>
    <sec id="Sec7">
     <title>
      Microbiota kati ya prebiotic na placebo
     </title>
     <p id="Par19">
      Hakuna sifa za vijidudu vilivyopatikana ambazo zilikuwa tofauti kwa kiwango cha kimaadili kati ya kundi la prebiotic na kundi la dawa bandia kwa msingi kama ilivyotathminiwa na PERMANOVA. Fig.
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      inaonyesha mlinganisho kati ya makundi kwenye mwisho wa masomo, ukiwaonyesha tofauti 11 muhimu, zikiendeshwa na wingi wa
      <italic>
       Bifidobacterium
      </italic>
      katika kundi la prebiotic, ikijumuisha wingi wa juu zaidi wa Actinobacteria hadi kiwango cha jeni, ongezeko dogo la phyla Firmicutes na Bacteroidetes, na kupungua kwa aina ya
      <italic>
       Phocea massiliensis
      </italic>
      na jeni yake. Zaidi ya hayo, Fig.
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      inaonyesha sifa 15 za vijidudu ambazo zilikuwa tofauti kwa kiwango cha kimaadili kati ya kundi la prebiotic na kundi la dawa bandia wakati wa kulinganisha wingi wa uwiano katika mwisho wa masomo uliobadilishwa kwa wingi wa msingi na jozi ya watu wanaoziungana. Zaidi ya athari kuu za kuongezeka kwa Bifidobacterium na kupungua kwa
      <italic>
       P. massiliensis
      </italic>
      zilizotazamwa katika uchambuzi wa ukata wa mvuke, kundi la prebiotic lina wingi wa chini wa
      <italic>
       Anaeromassilibacillus
      </italic>
      na chaguo la utakaso wa kiwango cha juu zaidi, kama vile Deltaproteobacteria, Lactobacillales, na Eubacteriales.
      <fig id="Fig2" position="float">
       <label>
        Fig. 2
       </label>
       <caption xml:lang="sw">
        <title>
         Ulinganisho kati ya vikundi vya prebiotic na placebo, ikijumuisha data kutoka mwisho wa masomo au tofauti kati ya awali na mwisho wa masomo.
        </title>
        <p>
         Ulinganisho wa kikundi kati ya wingi wa relative (a) na maradufu (p) ya vijidudu vya bakteria kati ya mikondo ya masomo cross-sectionally au mwishoni mwa masomo iliyosawazishwa kwa wingi wa awali wa vijidudu vya bakteria. Jaribio la tofauti za wingi wa vijidudu vya bakteria ilifanywa kwa mfumo wa mlolongo wa mstari na urekebishaji wa upendeleo wa muundo kulingana na LinDA. Hakukuwa na tofauti za kimaana kati ya vikundi mwanzoni au kwa ajili ya moduli za kimetaboliki za utumbo, moduli za utumbo-ubongo, au anuwai ya alpha. Saizi za athari ni viambajengo vilivyorekebishwa kwa upendeleo kutoka kwa miundo ya mstari ambapo saizi za athari chanya (bluu) zinaonyesha viwango vya juu zaidi katika kikundi cha placebo na saizi za athari hasi (nyekundu) zinaonyesha viwango vya juu zaidi katika kikundi cha prebiotic.
        </p>
       </caption>
       <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig2_HTML.png" mime-subtype="PNG" specific-use="web"/>
      </fig>
     </p>
     <p id="Par20">
      Hakukuwa na tofauti muhimu kati ya makundi ya prebiotic na dawa bandia kwa vipimo vyovyote vya aina nyingi za alpha. Pia hakukuwa na tofauti muhimu katika aina nyingi za beta kati ya makundi ya prebiotic na dawa bandia katika mwisho wa masomo kama ilivyotathminiwa na PERMANOVA. Kutofautiana kati ya jozi kwa aina nyingi za beta halikuonekana kuwa kikubwa zaidi katika mwisho wa masomo kuliko katika msingi (
      <italic>
       V
      </italic>
      = 102;
      <italic>
       p
      </italic>
      = 0.58). Fig. ya Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S7
      </xref>
      inaonyesha mlinganisho wa tofauti ya Bray–Curtis kati ya jozi za watu wanaoziungana, ikijumuisha ugawanyaji kwa zygosity.
     </p>
     <p id="Par21">
      Wakati wa kufanya mlinganisho ndani ya kikundi kati ya msingi na mwisho wa masomo, kulikuwa na sifa 40 muhimu zinazofanana wakati wa kulinganisha sampuli kutoka kwa kundi la prebiotic wakati wingi wa uwiano wa
      <italic>
       Actinomyces graevenitzii
      </italic>
      ulikuwa tofauti kwa kiwango cha kimaadili wakati wa kulinganisha sampuli kutoka kwa kundi la dawa bandia (Fig. ya Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S6
      </xref>
      ).
     </p>
    </sec>
    <sec id="Sec8">
     <title>
      Vipengele vya microbiota na nguvu za misuli
     </title>
     <p id="Par22">
      Katika muundo wa mstari uliobadilishwa kwa athari za kikundi na jozi ya watu wanaoziungana, sifa 129 za vijidudu zilikuwa na uhusiano muhimu na muda wa kufikia kiti, ikijumuisha taksa 95 za vijidudu, kazi 32 za vijidudu, na utajiri na anuwai ya kijeni ya Faith (Fig. ya Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S8
      </xref>
      ). Uchambuzi wa uhusiano (mgawo wa kuhusiana wa Pearson kutoka kwa miundo inayotumia wingi uliobadilishwa kwa uwiano wa logi) kati ya mabadiliko ya muda wa kufikia kiti na mabadiliko ya sifa za vijidudu katika kipindi cha uvamizi wa masomo (uchambuzi wa washiriki wote pamoja), ulionyesha uhusiano kati ya uboreshaji wa muda wa kufikia kiti na mabadiliko ya utajiri (
      <italic>
       r
      </italic>
      = −0.347;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0159), anuwai ya Shannon (
      <italic>
       r
      </italic>
      = −0.250;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0486), na anuwai ya Faith (
      <italic>
       r
      </italic>
      = −0.297;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0275) (Fig. ya Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ). Thamani za
      <italic>
       p
      </italic>
      zilizotolewa hapa zimebadilishwa kwa majaribio mengi.
     </p>
    </sec>
    <sec id="Sec9">
     <title>
      Vipengele vya microbiota na akili
     </title>
     <p id="Par23">
      Kwa kutumia mbinu ya uchambuzi wa uhusiano kati ya uwezo wa kimwili (muda wa kuinuka kwenye kiti) na vipengele vya microbiota hapo juu, tuligundua vipengele vitano vya microbiota ambavyo vilihusiana kwa kiwango cha kuaminika na uwezo wa kiakili (alama za kiwango cha akili) wakati wa kurekebisha athari za kundi na jozi za watu na kurekebisha upendeleo wa athari za usambazaji wa taxon kwa wingi (Supplementary Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S10
      </xref>
      ). Hii ilijumuisha phylum Actinobacteria (
      <italic>
       r
      </italic>
      = −0.323;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0447), ambayo iliongezeka kwa kiwango cha kuaminika katika kundi la prebiotic ikilinganishwa na kundi la placebo mwishoni mwa masomo. Uhusiano kati ya uboreshaji wa alama za kiwango cha akili pia ulihusiana na ongezeko la wingi wa Veillonellaceae na agizo lake la Veillonelalles kutoka mwanzo hadi mwisho wa masomo (
      <italic>
       r
      </italic>
      = 0.585,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0555, na
      <italic>
       r
      </italic>
      = 0.543,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0772, kwa mtiririko huo (Supplementary Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      )).
     </p>
    </sec>
   </sec>
  </sec>
  <sec id="Sec10" sec-type="discussion">
   <title>
    Jadiliano
   </title>
   <p id="Par24">
    Kukua kwa umri kunahusiana na kuongezeka kwa udhaifu na kuzorota kwa akili, zote mbili zinazoweza kuhusisha jukumu la microbiota ya utumbo. Katika jaribio hili la RCT, tulithibitisha kuwa prebiotic ilikuwa na uwezo wa kuvumilia na kusababisha mabadiliko ya microbiota ya utumbo, hasa na ongezeko la wingi wa
    <italic>
     Bifidobacterium
    </italic>
    <sup/>
    . Hata hivyo, hakukuwa na tofauti ya kimaadili katika matokeo ya msingi ya muda wa kuinuka kwenye kiti kati ya prebiotic na placebo, hata hivyo prebiotic iliboresha akili ikilinganishwa na placebo.
   </p>
   <sec id="Sec11">
    <title>
     Nguvu za misuli na utendaji
    </title>
    <p id="Par25">
     Hakuna ushahidi uliopatikana kwamba prebiotic hii iliboresha nguvu za misuli ikilinganishwa na placebo katika kipindi cha majuma 12, hasa kwa matokeo ya msingi ya muda wa kuinuka kwenye kiti. Zaidi ya hayo, hakukuwa na athari ya prebiotic kwenye matokeo ya pili yoyote yanayohusiana na nguvu za misuli na utendaji kazi ikijumuisha nguvu ya kushikamana na mikono, SPPB, au shughuli za kimwili (IPAQ).
    </p>
    <p id="Par26">
     Kipindi cha uingiliaji kati cha majuma 12 kilichochaguliwa kilianza kwenye masomo ya awali ya uingiliaji kati wa prebiotic
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="CR33">
       33
      </xref>
     </sup>
     . Hata hivyo, hakuna yoyote iliyolenga nguvu za misuli kama matokeo yake ya msingi. Muda huu unaweza kuwa haufikie kwa ajili ya kubadilisha misuli kutokea, na inawezekana kwamba kipindi cha uingiliaji kati kirefu zaidi kinahitajika ili kuthamini ushawishi wa ubadilishaji wa microbiota ya utumbo kwenye afya ya misuli. Wakati mwongozo wa EWGSOP2 unapendekeza muda wa kuinuka kwenye kiti kama kipimo cha nguvu za misuli, kazi zinazofuata zinapaswa kuzingatia kuongeza kipimo cha nguvu za misuli kinachotegemea isometric ambacho kina uwezo wa kugundua mabadiliko madogo katika misuli (kwa mfano, quadriceps) kwa kuongeza muda wa kuinuka kwenye kiti. Wakati muda wa kuinuka kwenye kiti unachukuliwa kuwa muhimu kwa watu wazee, unategemea nguvu, usawa, uonekano, n.k. na ni kipimo cha pili badala ya kipimo cha moja kwa moja cha nguvu. Mabadiliko makubwa yametajwa katika vipimo vya nguvu za misuli kwa watu wazee, ingawa vipimo kama vile muda wa kuinuka kwenye kiti na nguvu ya kushikamana na mikono vinaweza kutekelezwa kwa urahisi katika mazingira ya kimatibabu, vipimo vya nguvu vya moja kwa moja na vya kina vinapaswa kuzingatiwa katika utafiti wa siku zijazo unaozingatia kuthibitisha ufanisi wa ubadilishaji wa microbiota ya utumbo katika kuboresha matokeo ya misuli kwa watu wazee
     <sup>
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     .
    </p>
    <p id="Par27">
     Zaidi ya hayo, hesabu ya ukubwa wa sampuli yetu ilianza kwenye majaribio yaliyotangulia ambayo yalitumia muda wa kuinuka kwenye kiti kama matokeo yao ya msingi
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
     </sup>
     . Hata hivyo, hakuna jaribio lililopo ambalo lilikuwa limetumia uingiliaji kati wa microbiota, na kwa hiyo inawezekana kwamba masomo hayakuwa na nguvu za kutosha. Kwa hakika, tu sehemu moja ya tano (14/65; 8 katika kundi la prebiotic, 6 katika kundi la placebo,
     <italic>
      p
     </italic>
     = 0.68) ya wale waliofanyiwa vipimo vya muda wa kuinuka kwenye kiti kwa wakati wa mwanzo na mwisho wa masomo walifikia uboreshaji wa asilimia 20, ambao ulikuwa ubeoraji wa uboreshaji uliotumika katika hesabu ya ukubwa wa sampuli.
    </p>
    <p id="Par28">
     Kiasi cha prebiotic kilichotumika kilikuwa kimezingatiwa kulingana na jaribio lililofanya matumizi ya uingiliaji sawa katika wakazi wa nyumba za wazee
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Jaribio lililofanywa na Tandon et al. (2019) lilichunguza fructooligosaccharide (FOS) dosing kwa watu wazima wachanga na kutoa taarifa kwamba hakukuwa na tofauti muhimu za takwimu katika mabadiliko ya gut microbiota kwa kujibu 2.5 g/d, 5 g/d na 10 g/d doses (PROMOTe sachets zilikuwa na 7.5 g/d), hata hivyo kulikuwa na mwelekeo wa tofauti katika wingi wa
     <italic>
      Lactobacillus
     </italic>
     katika kundi la dosi ya juu
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
     </sup>
     . So et al. walifanya uchambuzi wa meta wa majaribio ya uingiliaji wa nyuzi za chakula, ambazo zingine nyingi zilijumuisha inulin na/au FOS, na kubainisha kuwa hakukuwa na tofauti katika athari kwenye wingi wa
     <italic>
      Bifidobacterium
     </italic>
     kwa dosi tofauti
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Walidhania kwamba huenda kuna kikomo cha kiasi cha nyuzi ambacho Bifidobacterium inaweza kuyeyusha, au labda ukosefu wa athari ya dosi-hutegemea huenda ukawa ni sifa ya ongezeko la asilimia kutoka kwa msingi badala ya dosi ya uingiliaji
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Matokeo yaliyotolewa hapa yanaonyesha kwamba dosi ya 7.5 g/d ilikuwa ya kutosha kuleta mabadiliko ndani ya gut microbiome. Hata hivyo, hakuna taarifa iliyopo kuhusu dosi ya kutosha ya prebiotics kwa matokeo ya kimwili kama vile nguvu ya misuli. Huenda dosi, ingawa ilikuwa ya kutosha kuleta mabadiliko ndani ya gut microbiome, haikuwa ya kutosha kutoa jibu muhimu kimatibabu kwa matokeo ya nguvu ya misuli ndani ya kikundi cha wachangiaji walio na afya
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     .
    </p>
    <p id="Par29">
     Hatimaye, wakati prebiotic iliyotumika katika jaribio hili ilionyesha kuboresha nguvu ya kushika, kiwango cha kuchoka, na kiwango cha ulemavu katika jaribio lingine la washiriki wazee, huenda prebiotic ya inulin/FOS si prebiotic bora zaidi kwa ajili ya kuathiri afya ya misuli, na utafiti zaidi unahitajika kubainisha prebiotic bora zaidi kwa lengo hili
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     Akili
    </title>
    <p id="Par30">
     Kwa upande wa matokeo ya pili, prebiotic iliboresha uelewa wa kimwili ikilinganishwa na kikundi cha dawa za kufikia. Kwa kutumia alama za kipengele kuchanganya vipengele vya CANTAB ya utambuzi, ni vigumu kubainisha kama kuboreshwa hiki ni muhimu kimatibabu. Jaribio pekee la utambuzi wa mtu binafsi ambalo lilikuwa na kuboreshwa kikubwa katika kundi la prebiotic dhidi ya kikundi cha dawa za kufikia kilikuwa idadi ya makosa katika jaribio la Paired Associates Learning, ambalo ni jaribio la kumbukumbu hasa linalotegemea kumbukumbu za kuona na kujifunza mpya
     <sup>
      <xref ref-type="bibr" rid="CR40">
       40
      </xref>
     </sup>
     . Kipimo hiki pia kimebainishwa kuwa kipimo cha mapema cha mienendo ya ugonjwa kama vile ugonjwa wa Alzheimer
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     .
    </p>
    <p id="Par31">
     Dhana ya mhimili wa utumbo-moyo, na microbiota inayotokana na njia za mawasiliano za mhimili wa utumbo-moyo, imejikita katika miaka ya hivi karibuni
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR42">
       42
      </xref>
     </sup>
     . Kuna njia tatu kuu za mawasiliano ya mhimili huu: ya neva, kinga, na endokrini
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
     </sup>
     . Kwa hakika, kuna ushahidi unaokua unaounga mkono uingiliaji kati unaolenga gut microbiome (pamoja na prebiotic) katika kuboresha uelewa wa kimwili
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Desmedt et al. walichunguza majaribio ya uingiliaji kati ya prebiotics kwenye athari za binadamu na uelewa wa kimwili na kupata masomo 14 yenye mbinu, matokeo, dosi ya prebiotic, na muda wa uingiliaji kati
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Karibu masomo yote yalilenga hisia na athari lakini kulikuwa na kuboreshwa kinachoonekana katika kumbukumbu ya kumbukumbu ya maneno na utambuzi ulioripotiwa. Hakuna masomo yaliyotumia majaribio ya utambuzi wa CANTAB. Kwa hiyo, ili kuthibitisha matokeo yetu, jaribio kubwa zaidi ambalo linajumuisha aina mbalimbali za majaribio ya utambuzi, pamoja na vipimo vya athari na ufahamu, na vipimo vya kina vya microbiome (muundo na kazi) vinahitajika.
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     Microbiota ya utumbo
    </title>
    <p id="Par32">
     Muhimu, uingiliaji kati wa prebiotic uliathiri muundo wa gut microbiota na kazi ya gut microbiota. Sifa 40 za microbiome zilibadilika kati ya msingi na mwisho wa jaribio kwa kikundi cha prebiotic, wakati moja tu ilibadilika katika kikundi cha dawa za kufikia (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     ). Sifa hizi zilijumuisha aina nyingi na wingi wa bakteria. Kupungua kwa aina nyingi kulionekana katika kikundi cha prebiotic, ambacho kinalingana na matokeo ya makundi mengine ya utafiti
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
     </sup>
     . Prebiotics kwa kawaida husababisha kuongezeka kwa wingi wa aina fulani badala ya aina nyingi, kama inavyoonekana katika Fig.
     <xref ref-type="fig" rid="Fig2">
      2
     </xref>
     na Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     , ambayo inaweza kusababisha kupungua kwa aina nyingi. Kikundi cha prebiotic kilikuwa na kuongezeka kikubwa kwa wingi wa Actinobacteria, hasa
     <italic>
      Bifidobacterium,
     </italic>
     ikilinganishwa na kikundi cha dawa za kufikia, ambayo imepatikana katika mahali pengine na uwasilishaji wa FOS na/au prebiotic ya inulin
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     . Kwa kweli, hakuna ongezeko la
     <italic>
      Lactobacillus
     </italic>
     au
     <italic>
      Facealibacterium
     </italic>
     lililoonekana, ambazo zimeonekana na watafiti wengine wengi katika masomo ya uingiliaji kati wa prebiotic, hasa fructans ya aina ya inulin, wakati wingi wa mila miwili inayofanana, Lactobacillales na Eubacteriales, mtawalia, ziliongezeka katika kikundi cha prebiotic ikilinganishwa na kikundi cha dawa za kufikia, ikionyesha kwamba aina zinazofanana zinaweza kuchukua jukumu pia
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR51">
       51
      </xref>
     </sup>
     .
    </p>
    <p id="Par33">
     Kwa kweli, licha ya moja ya wanandoa kwa kila jozi kupokea prebiotic na nyingine kupokea placebo, hakukuwa na mabadiliko ya kimaana katika tofauti za ndani za jozi kwenye mwisho wa utafiti. Kazi iliyopita imethibitisha kuwa mikrobiomu ya utumbo inaundwa na maumbile na mazingira ya mapema, na kuundwa kwa mapema na mafanikio ya ikolojia ya jumuiya. Kwa hivyo, utatuzi wa prebiotic wa wiki 12 ulikuwa haukutosha kubadilisha unganifu kati ya jozi za wanandoa, ambao wanashiriki maumbile, athari za mazingira ya mapema, na mara nyingi mambo mengi mengine. Uchambuzi wa urithi ulionyesha kuwa baadhi ya viumbe ambavyo tulipata kubadilika katika kipindi cha utatuzi (kwa mfano
     <italic>
      Bifidobacterium
     </italic>
     ) vilikuwa na urithi, ambao unaonyesha kuwa muundo wa utafiti wetu ulikuwa na nguvu kwa kutumia jozi za wanandoa, na muundo huo unaweza kuongeza uwezo wetu wa kugundua athari
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="CR53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="CR54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="CR55">
       55
      </xref>
     </sup>
     .
    </p>
    <p id="Par34">
     Kutoka kwa muundo hadi
     <italic>
      kazi
     </italic>
     ya mikrobiomu ya utumbo, baadhi ya GMMs zilipatikana kuwa na uhusiano mkubwa na uwezo wa kimwili kwa kujitegemea na jozi za wanandoa (Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ). Miongoni mwao kulikuwa na njia za kimetaboliki za amino asidi na wanga, pamoja na njia ya fosfeti ya pentosi; njia hii inatoa mabaki ya kibiosynthesis ya amino asidi na mabadiliko ya anabolism na ni muhimu katika anabolism ya misuli ya mifupa
     <sup>
      <xref ref-type="bibr" rid="CR56">
       56
      </xref>
      <xref ref-type="bibr" rid="CR57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="CR58">
       58
      </xref>
     </sup>
     . Matokeo haya yanatoa nguvu kwa dhana ya mhimili wa utumbo-misuli, ambayo inasema kuwa kuna uhusiano wa pande zote mbili kati ya mikrobiomu ya utumbo na misuli ya mifupa, ambayo inaweza kuwa na athari za kimetaboliki katika kuharibika kwa misuli ya mifupa kwa wazee, na inahitaji uchunguzi zaidi katika masomo ya siku zijazo yanayolenga jukumu la mikrobiomu ya utumbo katika upinzani wa anaboliki wa misuli ya mifupa kwa wazee
     <sup>
      <xref ref-type="bibr" rid="CR18">
       18
      </xref>
     </sup>
     .
    </p>
    <p id="Par35">
     Kuna ushahidi unaoongezeka unaounga mkono mhimili wa utumbo-ubongo, mfumo wa mawasiliano wa pande zote mbili kati ya mfumo wa neva kuu na wa ndani, ambapo mikrobiomu ya utumbo ina jukumu la msingi
     <sup>
      <xref ref-type="bibr" rid="CR59">
       59
      </xref>
     </sup>
     . Hapa, tunaripoti uhusiano chanya kati ya kuongezeka kwa alama za kipengele cha kiakili na wingi wa Actinobacteria kwenye mwisho wa utafiti, hata baada ya kurekebisha wingi wa msingi, mkondo wa utafiti, na jozi za wanandoa (Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S10
     </xref>
     ). Actinobacteria imehusishwa na kiakili katika mahali pengine na imehusishwa na ugonjwa wa Alzheimer na ugonjwa wa Parkinson
     <sup>
      <xref ref-type="bibr" rid="CR60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="CR61">
       61
      </xref>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     . Mwelekeo wa uhusiano unatofautiana kati ya masomo. Wakati imehusishwa na hali za ugonjwa, moja ya masomo ya watu 39 iliripoti wingi wa juu zaidi kuwa na uhusiano na kasi ya harakati na kusikiliza
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
     </sup>
     . Actinobacteria ni fani ambayo vijidudu vya
     <italic>
      Bifidobacterium
     </italic>
     vinahusiana nayo; kwa hivyo, ni muhimu kwamba masomo mengi ya utatuzi wa
     <italic>
      Bifidobacterium
     </italic>
     yameonyesha ahueni za matarajio katika kiakili
     <sup>
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
     </sup>
     . Zaidi ya utafiti unahitajika kuelewa uhusiano kati ya Actinobacteria na utendaji wa kiakili.
    </p>
   </sec>
   <sec id="Sec14">
    <title>
     Uwezo wa utafiti
    </title>
    <p id="Par36">
     Asili ya mbali ya jaribio hili la kimatibabu ni nguvu ya wazi na inaonyesha kuwa utatuzi uliotolewa kwa njia ya mbali unaweza kutekelezwa kwa ufanisi kwa wazee, na data nyingi zikokusanywa na kufuata vyema. Muundo huu wa utafiti una ahueni za kuboresha ushiriki mdogo wa wazee katika utafiti. Taasisi za kitaifa zimeitaka kuongezeka kwa ushirikishwaji katika utafiti wa kimatibabu, wakigundua wazee kama kundi lililo hatarini, na kutambua safari kama kikwazo kikuu cha ushiriki wao
     <sup>
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Zaidi ya hayo, vigezo vya kujumuisha kwa ajili ya kuajiriwa vilikuwa na lengo la kuwa wazi iwezekanavyo kwa watu wazee, ikiwa ni pamoja na wale wanaoishi na ulemavu na ugonjwa wa mara kwa mara.
    </p>
    <p id="Par37">
     Matukio mabaya zaidi yaliripotiwa katika kundi la prebiotic; hata hivyo, haya yalikuwa athari za upande zinazotarajiwa, ambazo washiriki walikuwa wamefahamishwa kuhusu hapo awali. Hakukuwa na tofauti katika kufuata maagizo kati ya mikondo miwili, ikimaanisha kuwa athari hizi za upande hazikuathiri kufuata maagizo. Kwa hivyo, utafiti huu umethibitisha uwezekano wa kutoa utatuzi wa mikrobiomu ya utumbo unaopatikana kwa bei nafuu na unaopatikana kwa wingi kwa idadi ya watu wazee. Masomo makubwa zaidi ya baadaye yanayotumia ukubwa wa sampuli kubwa, vipindi vya utatuzi virefu, na viwango tofauti vya utatuzi vinaweza kuchunguza uwezo wa mikrobiomu ya utumbo kusaidia upinzani wa anaboliki wa misuli ya mifupa kwa wazee.
    </p>
   </sec>
   <sec id="Sec15">
    <title>
     Nguvu na mapungufu
    </title>
    <p id="Par38">
     Nguvu kuu ya jaribio hili ni matumizi ya jozi za wanandoa zilizochaguliwa kwa kila mkondo wa utafiti, ambayo ilisababisha mikondo iliyofanana sana katika awali, na kuboresha uwezo wa kugundua athari za maana na kupunguza mwingiliano. Zaidi ya hayo, muundo huu ulikuwa jaribio la kimatibabu ndani ya kikundi, ambalo lilisababisha kuajiriwa kwa mafanikio kwa ukubwa wa sampuli kwa wakati na lengo.
    </p>
    <p id="Par39">
     Muundo wa utafiti uliofanyika mbali ni nguvu, kwani kuna hitaji la wazi la muundo wa majaribio mapya katika mazingira ya utafiti baada ya COVID, na kupunguza hitaji la kusafiri kwa washiriki wazee, ambao huenda wasitamani kuja katika mazingira ya hospitali au ambao huenda wana vikwazo vya harakati. Majaribio yaliyofanyika mbali yanaweza pia kusababisha kupungua kwa gharama za utafiti. Hata hivyo, usafirishaji mbali unaweza kuwanyima wale ambao hawana ujuzi wa kidijitali au ambao hawana ufikiaji wa kompyuta/meza na/au intaneti. Hii inaweza kuathiri zaidi wale wenye elimu ya chini, kiwango cha ufukara mkubwa, Kiingereza kama lugha ya pili, na mambo mengine yanayohusiana
     <sup>
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Mkusanyiko wa data pia unaweza kuwa si sahihi kama ilivyo katika utafiti uliofanyika kibinafsi, ingawa matumizi ya video teleconferencing yalipunguza tatizo hili.
    </p>
    <p id="Par40">
     Muundo wa utafiti uliofanyika mbali ulisababisha uwezekano wa kufanya kazi ya kupima misa ya mwili, ambayo ni kikomo. Ingawa misa ya mwili ni moja ya vipengele vya utambuzi wa sarcopenia, mwongozo wa Kikundi cha Ulaya cha Sarcopenia kwa Watu Wazee 2 (EWGSOP2) unapendekeza nguvu ya mwili kama kipengele muhimu zaidi cha kutambua
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     . Majaribio ya siku zijazo yanayochunguza mbinu zinazolenga mhimili wa utumbo-mwili yanapaswa kujumuisha kipimo cha misa ya mwili ili kuchunguza uhusiano huu.
    </p>
    <p id="Par41">
     Kukosekana kwa data kilikuwa kikubwa zaidi kwa majaribio ya kiakili ya CANTAB ikilinganishwa na vigezo vingine vya matokeo. Hii ilikuwa inawezekana kwa sababu ya mzigo wa kufanya majaribio ya CANTAB nyumbani, ambayo inaweza kuwa ya muda mrefu, na programu hiyo haifanyi kazi kwa vifaa vyote vya meza. Baadhi ya washiriki waliotumia vifaa vya meza hawakuweza kuifanya programu hiyo kufanya kazi kwenye vifaa vyao.
    </p>
    <p id="Par42">
     Vipimo vya mikrobiomu ya utumbo vilichukuliwa katika pointi mbili za muda, mwanzo na mwisho wa utafiti. Bila chombo cha kati cha utafiti, hatuwezi kusema kama matokeo ya mikrobiomu ya utumbo katika mwisho wa utafiti yanawakilisha urejeshaji wa sehemu kutoka kwa mbinu ya prebiotic. Ukubwa wa sampuli kubwa na muda mrefu wa mbinu unaweza kuhitajika ili kujaribu hili. Zaidi ya hayo, uchambuzi wa kazi wa mikrobiomu ya utumbo katika utafiti huu unategemea data ya metagenomic badala ya kipimo cha moja kwa moja. Utafiti wa siku zijazo unaweza kuchunguza meta-transkriptomikia au metaboli ya mkojo ili kuchunguza zaidi. Maltodextrin ni kiinshi kinachotumiwa kwa kawaida kama dawa ya kudanganya katika majaribio ya prebiotics, lakini ina vikwazo, kwani si moja kwa moja inayolingana na nishati ya prebiotic. Majaribio ya siku zijazo yanaweza kutumia dawa ya kudanganya inayolingana na nishati ili kushinda hili.
    </p>
    <p id="Par43">
     Kundi la TwinsUK, ambalo washiriki waliochaguliwa, ni wengi wanawake kwa sababu za kihistoria na lina upendeleo wa mwanachama mzuri
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Hata hivyo, ni wakilishi wakubwa wa idadi ya watu wa Uingereza
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Utafiti huu ulikuwa unalenga kuangalia wale wanaozidi miaka 60, na kwa hiyo, hauna uwezo wa kuwakilisha vikundi vya umri mdogo. Zaidi ya hayo, asili ya wengi wanawake kati ya washiriki ina vikwazo vya kiasi fulani vya uwezo wa kuwakilisha. Kazi za siku zijazo katika eneo hili zinapaswa kujumuisha watu wazima wa kati, wazee zaidi, na uwakilishi mkubwa wa wanaume.
    </p>
   </sec>
   <sec id="Sec16">
    <title>
     Hitimisho la majadiliano
    </title>
    <p id="Par44">
     Vitamini vya prebioti viliboresha uelewa wa akili lakini havikuathiri nguvu na utendaji wa misuli, ikilinganishwa na kikundi cha dawa za kufasiri katika kundi la wazee walio na afya njema. Matokeo yetu yanaonyesha kuwa usaidizi wa prebioti unaoletwa na utando wa utumbo una uwezo wa kuboresha udhaifu wa akili katika idadi ya watu wazee. Ingawa jaribio hili halijathibitisha kuboreshwa kwa nguvu ya misuli ya mifupa, tulionyesha kuwa mabadiliko ya utando wa utumbo kwa njia ya prebioti katika muktadha wa utafiti wa misuli na umri ni ya kufaa na kuendelea vyema, na majibu wazi yaliyotambuliwa katika muundo na utendaji wa utando wa utumbo. Majaribio makubwa zaidi yanaweza kuchunguza matumizi ya usaidizi wa utando wa utumbo unaolenga kushinda upinzani wa umri unaohusiana na anaboliki. Pia tunaeleza uwezekano wa majaribio yanayotolewa kwa njia ya mbali kwa watu wazee, ambayo ina matumaini ya kuboresha utafiti katika eneo hili, kwa lengo la kupunguza uwakilishi mdogo wa watu wazee katika majaribio ya kimatibabu na kupunguza gharama za utafiti.
    </p>
   </sec>
  </sec>
  <sec id="Sec17" sec-type="methods">
   <title>
    Michakato
   </title>
   <p id="Par45">
    Muundo wa utafiti umetajwa kwa undani katika kifungu kilichochapishwa awali
    <sup>
     <xref ref-type="bibr" rid="CR69">
      69
     </xref>
    </sup>
    . Kwa ufupi, jaribio la PROMOTe (athari ya PRebioti na prOtiini kwenye misuli ya Wazee wa Zigote) lilikuwa jaribio la udhibiti lililodhibitiwa kwa nasibu ambapo jozi za zigote (monozygotic na dizygotic) zilichaguliwa kwa nasibu, zigote moja kwa kila mkono wa jaribio. Zigote zote mbili zilikuwa zikichukua kiungo cha protini (BCAA) cha unga, na katika zigote moja kwa kila jozi, hii ilichanganywa na kiungo cha prebioti (inulin na fructo-oligosaccharides) na katika zigote nyingine kwa kila jozi, ilichanganywa na dawa za kufasiri (maltodextrin). Viungo hivi vilivyochanganywa vilikuwa kwenye sacheti zinazofanana, na kila mshiriki alishauriwa kuchukua sacheti moja kwa siku kwa muda wa wiki 12 kwenye glasi ya maji au kinywaji kingine kwa wakati mmoja kila siku. Tulishauri washiriki katika vikundi vyote viwili kujihusisha na mazoezi ya upinzani.
   </p>
   <p id="Par46">
    Jaribio hili lilifanywa kwa njia ya mbali, kwa kutumia mifuko ya posta kusambaza usaidizi na kukusanya vipimo na sampuli kutoka kwa washiriki na aina mbalimbali za teknolojia, ikijumuisha mawasiliano ya video, maswali ya mtandaoni, majaribio ya akili ya mtandaoni, na programu ya kuandika chakula ya mtandaoni. Muundo huu wa utafiti ulichaguliwa kwa sehemu kwa sababu ya janga la COVID-19 na vikwazo vinavyohusiana na usafiri, pamoja na wasiwasi unaowezekana kati ya watu wazee kuhusu kuhudhuria kituo cha hospitali. Zaidi ya hayo, watu wazee wengi wanaweza kupata shida ya kusafiri kwa sababu mbalimbali na Taasisi ya Taifa ya Utafiti wa Afya imeitaka muundo wa utafiti wa ubunifu ili kuboresha uwakilishi wa makundi yaliyotengwa, ikijumuisha watu wazee
    <sup>
     <xref ref-type="bibr" rid="CR66">
      66
     </xref>
     ,
     <xref ref-type="bibr" rid="CR70">
      70
     </xref>
    </sup>
    . Hii ilifanywa iwezekane kwa sababu ya kuongezeka kwa ujuzi wa intaneti na teknolojia kati ya watu wazee, ambayo iliharibika na ufunguzi wa janga la COVID-19
    <sup>
     <xref ref-type="bibr" rid="CR71">
      71
     </xref>
     ,
     <xref ref-type="bibr" rid="CR72">
      72
     </xref>
    </sup>
    .
   </p>
   <p id="Par47">
    Mwendo wa utafiti na hatua zilizochukuliwa zinaonyeshwa katika Fig.
    <xref ref-type="fig" rid="Fig3">
     3
    </xref>
    <sup/>
    . Washiriki wote walipokea mfuko wa posta wenye vifaa vyote vinavyohitajika na maelekezo ya kuchukua sampuli za kibaolojia, ikijumuisha vibarua vya kurudisha, dinamometa ya kupima nguvu ya kugonga (Kuptone; Modeli EH101), riboni yenye urefu wa mita nne ili kusaidia kupima kasi ya kutembea na teipi ya kupima urefu. Washiriki walikuwa na fursa ya kuuliza watafiti kwa maelezo zaidi kuhusu sehemu yoyote ya jaribio wakati wa ziara ya mawasiliano ya video.
    <fig id="Fig3" position="float">
     <label>
      Fig. 3
     </label>
     <caption xml:lang="sw">
      <title>
       Mchoro wa utafiti.
      </title>
      <p>
       Kichunguzi: Mchoro huu ulichapishwa hapo awali katika kifungu cha utafiti
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       . Imetolewa na idhini ya Ni Lochlainn et al.
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       .
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig3_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
   </p>
   <p id="Par48">
    Data ya jinsia ilibadilishwa kulingana na taarifa za kibinafsi kutoka kwa washiriki. Zigote zote zilikuwa za jinsia moja. Jinsia haikusomwa. Kupima urefu ulifanywa na mshiriki mwenyewe kwa kutumia teipi iliyotolewa katika mfuko wa posta. Washiriki walishauriwa kujipima wenyewe ikiwa walikuwa na kizani cha kupima. Mizani ya kupima inaweza kuthibitishwa kwa kutumia bidhaa ya kawaida ya nyumbani, kama vile tin ya maharagwe. Jaribio la Utendaji wa Kimwili la Mfupi (SPPB) lilifanywa kwa njia ya mbali (hii inajumuisha muda wa kuinuka kwenye kiti), na maelekezo ya wakati halisi kutoka kwa mtafiti aliyejifunza. Nguvu ya kugonga mikono ilitolewa kwa kutumia dinamometa iliyotolewa, na mwongozo kutoka kwa mtafiti aliyejifunza, wakati wa kuitikia simu za video. Sampuli za kinyesi zilichukuliwa na washiriki wenyewe kwa kutumia vifaa vya kuchukua sampuli vilivyotolewa. Zigote zilishauriwa kuchukua sampuli ya kinyesi ya saizi ya karanga kwenye tube ya kukusanya sampuli za DNA/RNA (Zymo Research), na hizi zilipokwa kwenye maabara. Baada ya kupokea, sampuli zilichakatwa kwa kutumia tumboni za kioevu, vortexing, centrifugation na kugawanya kwa ajili ya uhifadhi wa muda mfupi na mrefu kwa -80 °C. Uchujaji wa DNA wa vimelea ulifanywa kwa sampuli zote kwa kutumia kifaa cha uchujaji wa MagMax Core Nucleic Acid Purification na kifaa cha uchujaji wa MagMax Core Mechanical Lysis. Kipande hiki kilikuwa kimeundwa kwa ajili ya uzito wa kuanzia wa gramu 1/ml ya kinyesi na kiasi cha mwisho cha 100 µl. DNA iliyofuata ilihifadhiwa kwa -20 °C kwa muda mrefu. DNA ya vimelea ilipelekwa kwa
    <italic>
     Clinical Microbiomics Ltd
    </italic>
    <sup/>
    . kwa ajili ya uchambuzi wa utando wa utumbo kwa kutumia usafirishaji wa metagenomic wa shotgun (tazama Kumbukumbu ya Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     1
    </xref>
    kwa mbinu ya kina).
   </p>
   <p id="Par49">
    Majaribio ya kiakili kutoka kwa betri ya CANTAB yalijumuisha majaribio ya utendaji wa kiutendaji, hasa One Touch Stockings of Cambridge na majaribio ya kumbukumbu ya kazi ya nafasi, na majaribio ya kumbukumbu, hasa anuwai ya nafasi, kumbukumbu ya utambuzi, na kujifunza kwa wanafunzi
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
    </sup>
    . Data ya kumbukumbu ya chakula ya siku tatu zilijazwa na kuchambuliwa kwenye programu ya
    <italic>
     MyFood24
    </italic>
    ya mtandaoni
    <sup>
     <xref ref-type="bibr" rid="CR73">
      73
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
    </sup>
    .
   </p>
   <p id="Par50">
    Washiriki walichukuliwa kuwa wanaotii kwa nyongeza ikiwa walijibu swali ‘Je, umekuwa unachukua nyongeza zako kila siku?’ kwa kusema ‘Ndiyo—kila siku’ au ‘Karibu kila siku’ na walichukuliwa kuwa wanaotii kwa mazoezi ikiwa waliripoti kutekeleza mazoezi mara mbili kwa wiki au zaidi. Hatimaye, washiriki walitakiwa kushikilia sacheti zilizobaki wakati wa ziara yao ya mwisho ya video ili zihesabiwe. Nambari hii ililinganishwa na idadi ya siku tangu mchukuaji alianza utafiti, na asilimia ya utii ilihesabiwa. Utafiti huu ulirejeshwa kwenye ClinicalTrials.gov (NCT04309292).
   </p>
   <sec id="Sec18">
    <title>
     Vigezo vya kujumuisha/kutengwa
    </title>
    <p id="Par51">
     Washiriki walikuwa wanaofaa kujumuishwa ikiwa walikuwa na umri wa miaka 60 au zaidi na walikuwa wametangulia kuripoti matumizi ya chini ya protini ya lishe (&lt;1 g/kg uzito wa mwili/siku) kulingana na mwongozo wa Jumuiya ya Ulimwengu ya Lishe na Metabolism (ESPEN) kwa watu wazima
     <sup>
      <xref ref-type="bibr" rid="CR8">
       8
      </xref>
     </sup>
     . Hii ilichaguliwa badala ya Kiasi cha Lishe kilichopendekezwa (RNI) kwa protini nchini Uingereza (0.8 g/kg/siku) kwa sababu ya upinzani wa kimetaboliki wa misuli ya mifupa unaohusiana na kuzeeka. Matumizi ya protini ili kubainisha kujiunga na utafiti yalipimwa mapema ndani ya kikundi cha TwinsUK. Kwa kuongeza, washiriki walihitaji kuwa na ufikiaji wa kompyuta au kifaa cha meza, ili waweze kukamilisha ziara za mbali kwa njia ya video teleconferencing. Vigezo vya kujumuisha vilijumuisha ugonjwa wa chakula kali, matumizi ya hivi karibuni (kutangulia miezi 3) ya viuavijasumu, nyongeza za protini, prebiotics au probiotics, ugonjwa wa figo hatari zaidi ya hatua 3, hasara ya uzito wa ≥5% ya uzito wa mwili katika miezi 12 iliyopita, majeraha au upasuaji wowote ambao unaharibu utendaji wa kimwili, na ushiriki katika masomo mengine ya kuingilia. Vigezo hivi vilichaguliwa ili kuepuka vikwazo vya matibabu, kuepuka uchafuzi wa data iliyokusanywa, kwa mfano, na matumizi ya hivi karibuni ya nyongeza ya protini, na kuongeza uaminifu wa sampuli za gut microbiota zilizokusanywa, kwa mfano, kwa kutoa matumizi ya hivi karibuni ya viuavijasumu na ugonjwa mkubwa wa utumbo.
    </p>
   </sec>
   <sec id="Sec19">
    <title>
     Uingiliaji kati wa utafiti
    </title>
    <p id="Par52">
     Washiriki walipewa sacheti za nyongeza za chakula katika umbo la unga. Sacheti zote zilikuwa na 3.32 g ya unga wa protini wa asidi ya mshazari ya branched, ikijumuisha
     <sc>
      l
     </sc>
     -leucine 1660 mg,
     <sc>
      l
     </sc>
     -isoleucine 830 mg, na
     <sc>
      l
     </sc>
     -valine 830 mg. Sacheti za mkono wa utatuzi zilikuwa na 7.5 g ya prebiotic (Darmocare Pre®, Bonusan), ambayo ina inulin (min. 3375 mg) na fructo-oligosaccharides (FOS) (min. 3488 mg). Sacheti za kipimo cha kawaida zilikuwa na 7.5 g ya unga wa maltodextrin. Nyongeza hizi zote za chakula zinapatikana kwa njia ya kibiashara bila agizo la daktari. Chaguo la prebiotic liliteuliwa kulingana na jaribio linalotumia utatuzi sawa, ambalo lilionyesha kuwa na nguvu ya kushikamana na kiwango cha uchovu, mbili ya vigezo vya Fried vya ulemavu katika idadi ya watu wazima
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Maltodextrin inatumika kwa kawaida kama kipimo cha kawaida katika utafiti wa gut microbiome na lishe
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     .
    </p>
    <p id="Par53">
     Sacheti za mikono yote miwili zilitengenezwa ili kuwa na sacheti zisizoweza kutofautishwa, zinazotambulika kwa nambari ya nasibu, ambayo ilikuwa inapatikana tu na Kituo cha Jaribio cha Kimatibabu cha King (KCTU), ambacho kilifanya uwekaji nasibu kwa ajili ya utafiti. Uwekaji nasibu na ugawaji wa mkono ulifanywa kwa njia ya mbali na KCTU, ambao alitoa nambari inayolingana kwa ajili ya sacheti sahihi kupelekwa kwa kila mshiriki na timu ya utafiti. Uwekaji nasibu ulifanywa kama jozi za watu wawili, kila jozi kama kizuizi cha mara kwa mara cha wawili—mmoja wa watu wawili katika kila jozi aliwekwa nasibu kwenye kila mkono. Washiriki wote na watafiti walikuwa hawajui hadi uchambuzi wa data ulikamilika.
    </p>
    <p id="Par54">
     Washiriki wote walitakiwa kuhifadhi sachets zilizosalia mwishoni mwa kipindi cha jaribio kama kipimo cha utii. Hatimaye, washiriki wote walishawishiwa kujihusisha na mazoezi ya upinzani ya mara kwa mara angalau mara mbili kwa wiki kwa muda wote wa uingiliaji kati na walipewa ushauri ulioandikwa kuhusu hilo mwanzoni mwa masomo, unaopatikana kutoka kwa tovuti ya NHS:
     <ext-link ext-link-type="uri" href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
      https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
     </ext-link>
     <sup>
      <xref ref-type="bibr" rid="CR75">
       75
      </xref>
     </sup>
     . Mazoezi ya nguvu yalijumuisha squats, calf raises, sit-to-stand, leg lifts, leg extensions, wall press ups na bicep curls. Mazoezi haya yanashauriwa kwa wazee, yanaweza kufanywa katika nyumba zao, na hayawakilishi programu kubwa ya mazoezi. Nakala za ujumbe wa maneno zililetwa kila wiki kwa muda wa uingiliaji kati ili kuwahimiza washiriki kuzingatia mazoezi na sachets za kiungo.
    </p>
   </sec>
   <sec id="Sec20">
    <title>
     Matokeo
    </title>
    <p id="Par55">
     Matokeo yalikusanywa katika ziara za masomo kwa njia ya video teleconferencing, kwa njia ya kukamilisha maswali ya mbali, daftari la chakula la siku 3 ili kupima protini na wingi mwingine wa chakula ili kuhesabu tofauti zozote za matumizi ambayo zingeweza kusababisha mkanganyiko na betri ya jaribio la akili, na kwa njia ya kupokea namna za kibaolojia kutoka kwa washiriki. Matokeo ya msingi yalikuwa mabadiliko ya muda wa kufikia kiti (muda wa kufanya mikiti 5 bila kutumia mikono), uliopimwa mwanzoni na mwisho wa masomo. Muda wa kufikia kiti ni sehemu ya betri ya utendaji wa kimwili mfupi na unahusiana na maisha bora, utendaji wa kimwili, ulemavu, ugonjwa wa zaidi ya moja na, kwa hakika, utendaji wa akili
     <sup>
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
     </sup>
     . Ni kipimo kinachoshauriwa cha nguvu katika mwongozo wa Kikundi cha Ushirikiano wa Ulaya kwa ajili ya Sarcopenia ya Watu Wazee 2
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     .
    </p>
    <p id="Par56">
     Matokeo ya pili yalijumuisha alama ya kipimo cha akili, alama ya SPPB (ikiwa ni pamoja na muda wa kufikia kiti na kasi ya kutembea), nguvu ya kugonga, kasi ya kutembea, kiwango cha shughuli za kimwili kwa kutumia Swali la Kimataifa la Shughuli za Kimwili (IPAQ) na alama ya tathmini ya lishe iliyoorodheshwa (SNAQ).
    </p>
   </sec>
   <sec id="Sec21">
    <title>
     Microbiota ya utumbo
    </title>
    <p id="Par57">
     Mbinu kamili ya utambuzi wa viumbe vidogo vya gut microbiome imepewa katika Kumbukumbu ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup/>
     . Kwa ufupi, jumla ya 137 DNA aliquots zilichambuliwa hadi kina cha wastani wa milioni 21.6 (M) jozi za kusoma (Illumina 2 × 150 PE) kwa kila sampuli. Uchafuzi wa mwenyeji uliondolewa, viambatisho na besi zilitolewa kwa kutafuna, na jozi za kusoma ambazo zilipita uchunguzi kwa urefu wa angalau 100 bp zilishikiliwa; hizi ziligitajwa kama kusoma kwa ubora wa juu wa si mwenyeji (HQNH). Asilimia 82.8 ya kusoma HQNH zilipeanwa kwenye orodha ya jeni ya Clinical Microbiomics ya utumbo wa binadamu kwa kutumia BWA mem (v. 0.7.17)
     <sup>
      <xref ref-type="bibr" rid="CR78">
       78
      </xref>
     </sup>
     . Aina 326 za viumbe vidogo vya Metagenomic (MGSs) zilitambuliwa kwa wastani kwa kila sampuli. Ili kutoa taarifa za kibiolojia za MGS, jeni zake zilichambuliwa dhidi ya jeni za prokaryotic za NCBI RefSeq (2022-01-19), na msingi wa data nt (2021-08-03) na kanuni za utambuzi za ngazi zilitumika. Mifano ya wingi wa MGS iliyopunguzwa ilihesabiwa kwa kutumia sampuli isiyo na ubadilishaji, bila kubadilishana, ya idadi isiyo na kikomo ya hesabu za jeni za kipeo kwa kila sampuli na kisha kufuata utaratibu ulioelezwa hapo juu. Katika masomo haya, hesabu za jeni za kipeo 431127 zilitumika. Utambuzi wa kazi na utambuzi wa viumbe vidogo vya microbiome ulifanywa kwa kutumia EggNOG mapper (v. 2.0.1), Diamond mode, na moduli za KEGG (v. 78.2)
     <sup>
      <xref ref-type="bibr" rid="CR79">
       79
      </xref>
      <xref ref-type="bibr" rid="CR80">
       80
      </xref>
     </sup>
     .
    </p>
    <p id="Par58">
     Uchambuzi wote wa viumbe vidogo vya microbiome ulitumia wingi uliopunguzwa kwa mlinganisho wa vikundi, wakati viwango vya aina alpha na beta vilihesabiwa kutoka kwa matrix za wingi zilizopunguzwa zilizotengenezwa kwa kutumia sampuli isiyo na ubadilishaji ya kusoma
     <sup>
      <xref ref-type="bibr" rid="CR81">
       81
      </xref>
     </sup>
     . Aina alpha inarejelea aina ndani ya sampuli, wakati viwango vya aina beta ni makadirio ya usawa/utofauti kati ya sampuli. Ndani ya kila aina ya data (kwa mfano, jeni, MGS), sampuli zote zilikuwa na idadi sawa ya kusoma muhimu: kupunguza wingi wa MGS ulifanywa kwa kutumia sampuli tu kutoka kwa kusoma zinazopeana na jeni za kipeo za MGS, na kupunguza wingi wa KEGG orthology (KO) ulifanywa kwa kutumia sampuli tu kutoka kwa kusoma zilizopeana na jeni iliyo na KO iliyopewa. Hata hivyo, kupunguza wingi wa jeni ulifanywa kwa kutumia kusoma zilizopeana na orodha nzima ya jeni. Aina alpha ilihesabiwa kama idadi ya viumbe vidogo vilivyopatikana (wingi), kama indeksi ya Shannon kulingana na logariti ya asili, au kama aina ya kibiolojia ya Faith. Aina beta ilihesabiwa kama tofauti ya Bray-Curtis na umbali wa weighted UniFrac.
    </p>
    <p id="Par59">
     Ufanisi kati ya jozi za watu waliotwin ilichunguzwa kwa kutumia jaribio la Mann–Whitney
     <italic>
      U
     </italic>
     na kulinganisha na jozi zisizo za watu waliotwin kwa sababu mambo mengi ya ndani na ya mazingira, kama vile chakula, jiografia, aina ya maisha, hali ya kuishi pamoja, na genetiki za mwenyeji huathiri microbiome ya mwenyeji
     <sup>
      <xref ref-type="bibr" rid="CR82">
       82
      </xref>
     </sup>
     . Uchambuzi wa urithi wa fomu rasmi ulifanywa kwa kutumia muundo wa ACE kama ilivyoelezwa, ili kujua kama ufanano wa microbiota kati ya watu waliotwin unaweza kuhusishwa na urithi wa vijidudu vya microbe
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec22">
    <title>
     Hesabu ya ukubwa wa sampuli
    </title>
    <p id="Par60">
     Kutoka kwa data iliyopo ndani ya kikundi cha TwinsUK, tuligundua kuwa muda wa kuinuka kwenye kiti ulikuwa karibu na log-normal, na log10(muda wa kuinuka kwenye kiti) ulikuwa na SD ya 0.126. Tuliikubali kuwa kupungua kwa asilimia 20 kwa muda wa kuinuka kwenye kiti kuwa na uwezekano na umuhimu wa kimatibabu. Tuliitegemea hii kwenye masomo yaliyotangulia yanayotumia muda wa kuinuka kwenye kiti, hata hivyo, ilibainishwa kuwa hakuna masomo yaliyojaribu hili katika muktadha wa utafiti unaolenga microbiome ya utumbo. Kwa mujibu wa takwimu hizi, tulihesabu kuwa tungehitaji data kamili kwa washiriki 28 kwa kila kundi (56 kwa jumla) kwa nguvu ya 80%. Kwa kuzingatia kuwa 20% ya washiriki wangeweza kujiondoa, tulihitaji
     <italic>
      n
     </italic>
     = 70 washiriki wajibiwe (35 kwa kila kundi). Kutumia watu waliotwin huongeza nguvu ya utafiti kwa sababu ya usawazisho wa karibu katika awali, na kupunguza mabadiliko ya kijeni na ya mazingira, na hivyo kupunguza upotoshaji
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
      <xref ref-type="bibr" rid="CR83">
       83
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec23">
    <title>
     Uchambuzi wa takwimu
    </title>
    <p id="Par61">
     Uchambuzi ulifanywa kwa kutumia toleo la Stata SE la 15.1, isipokuwa uchanganuzi wa microbiome ya utumbo, ambao ulifanywa kwa kutumia toleo la R la 4.2.1
     <sup>
      <xref ref-type="bibr" rid="CR84">
       84
      </xref>
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
     </sup>
     . Ufichuzi wa vikundi vya uhusiano ulifanywa tu baada ya uchanganuzi wote wa takwimu kuwa kamili. Thamani ya
     <italic>
      P
     </italic>
     ya pande zote mbili ya &lt;0.05 ilichukuliwa kuwa muhimu kwa uchanganuzi wote. Washiriki hawakutengwa ikiwa walikuwa na data ya kutowezekana ya awali ya mabadiliko ya awali ili kutosheleza kanuni za mbinu ya kutibu kama ilivyo (ITT). Kwa hivyo, kwa data ya kutowezekana katika kundi hili, mbinu za kubadilisha maana zilitumika. Vile vile, kwa baadhi ya vigezo, thamani ya hivi majuzi zaidi kutoka kwa data ya muda mrefu ya kikundi cha TwinsUK ilibadilishwa ikiwa zilichukuliwa kuwa ndani ya kipindi kinachofaa. Maamuzi ya mbinu za kubadilisha yalifanywa kabla ya kufichua.
    </p>
    <p id="Par62">
     Kwa mujibu wa data ya matokeo yaliyokosekana, kwa madhumuni ya uchanganuzi mkuu, ilidhaniwa kuwa data iliyokosekana ilikuwa imekosekana kwa nasibu, na athari ya utafiti ilikuwa sawa kwa wale walio na na wale wasio na maoni. Hakuna ushahidi uliopatikana wa kupotosha kwa data iliyokosekana ndani ya kila ugawaji wa matibabu.
    </p>
    <p id="Par63">
     Ili kulinganisha wale walioikataa au waliozuiliwa kushiriki, na wale waliojibu, data ya muda mrefu ya kikundi cha TwinsUK ilitumika. Jaribio la t la pande mbili lililotumika kwa kila kundi. Tofauti kati ya makundi mawili kwa mujibu wa jinsia ilirekebishwa kwa umri, na vivyo hivyo, tofauti kati ya makundi mawili kwa mujibu wa umri ilirekebishwa kwa jinsia ili kujua kama moja ya vigezo hivi vilikuwa vinavyoendesha mabadiliko kati ya makundi mawili.
    </p>
    <p id="Par64">
     Ilikuza tofauti kati ya mikono ya utafiti kwa msingi, vigeu vya mfululizo vililinganishwa kwa kutumia majaribio ya sampuli mbili ya
     <italic>
      t
     </italic>
     - na vigeu vya aina moja vililinganishwa kwa kutumia majaribio ya chi mraba ya Pearson. Majaribio ya
     <italic>
      t
     </italic>
     ya jozi zilizo upande mmoja yalitumika kulinganisha data ya lishe kati ya msingi na mwisho wa utafiti.
    </p>
    <p id="Par65">
     Ili kuchunguza kumbukumbu kwa ujumla, alama ya uchambuzi wa sababu iliyotumika kuchanganya matokeo ya majaribio 5 ya kumbukumbu (Kumbukumbu ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Mizani ya sababu kutoka kwa msingi ilitumika kwa matokeo ya majaribio ya kumbukumbu ya msingi na mwisho wa utafiti ili kuhakikisha mizani sawa. Sababu moja ilitambuliwa kutoka kwa grafu ya scree kama inayotoa tofauti ya uwiano mkubwa. Kwa hivyo, alama ya sababu kwa msingi na mwisho wa utafiti ilitolewa na kisha kutumika katika miundo ya athari zilizochanganywa. Miundo ya athari zilizo na matokeo ya mseto yalitumika kulinganisha vikundi vya utafiti (mkono 1 dhidi ya mkono 2; iliyofungiwa) kwenye mabadiliko yao katika kila matokeo kwa kutumia kipimo cha matokeo hayo kwa mwisho wa utafiti na kujumuisha kipimo cha msingi katika muundo. Ujumuishaji wa kijamaa ulichukuliwa kama athari ya nasibu, na kitambulisho cha familia na zygosity, na kikundi cha matibabu kama athari ya mara kwa mara. Majaribio ya
     <italic>
      t
     </italic>
     ya jozi zilizo upande mmoja yalitumika kwa mlinganisho ndani ya kikundi kati ya msingi na mwisho wa utafiti.
    </p>
    <p id="Par66">
     Ili kuangalia matumizi ya virutubisho kwa kuzidi na kuchukua zaidi ya kiasi, viwango vya Goldberg vya matumizi ya nishati vililinganishwa na uwiano wa kiwango cha msingi cha kimetaboliki na kuzidishwa kwa kipengele cha 1.4 kuhesabu shughuli za kimwili
     <sup>
      <xref ref-type="bibr" rid="CR86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="CR87">
       87
      </xref>
      <xref ref-type="bibr" rid="CR88">
       88
      </xref>
     </sup>
     . Kiwango cha shughuli za kimwili ‘nyepesi’ kilichochaguliwa kulingana na alama za IPAQ za washiriki kwa msingi.
    </p>
    <p id="Par67">
     Sifa za vijidudu vya utumbo (muundo, kazi, vipimo vya aina mbalimbali, GMMs, na GBMs) zililinganishwa kati ya mikono ya utafiti ya prebiotic na placebo kwa msingi na mwisho wa utafiti kwa kutumia jaribio la Wilcoxon lililohesabiwa. Zaidi ya hayo, mlinganisho ndani ya kikundi kati ya msingi na mwisho ulifanyika kwa kila mkono kibinafsi. Tumethibitisha kama sifa yoyote ya vijidudu vya utumbo ilihusiana na matokeo ya msingi ya muda wa kuinuka kwenye kiti ama kwa msingi, mwisho wa utafiti au mabadiliko kati ya hizo mbili. Mabadiliko katika kipengele cha vijidudu vya utumbo yalichomekwa kwenye uchanganuzi wa uhusiano dhidi ya mabadiliko katika muda wa kuinuka kwenye kiti na mabadiliko katika alama ya sababu ya kumbukumbu. Vigeu vyote vya mabadiliko ni tofauti kati ya msingi na mwisho wa utafiti. Ili kuhesabu mabadiliko katika sifa za vijidudu vya utumbo, uwepo wa asili uliotumika, na maadili ya delta yaliyosababishwa yalibadilishwa kwa uwiano wa logi na kutumika kama ingizo kwa miundo ya mstari.
    </p>
    <p id="Par68">
     Milinganyo ya jozi ya usawa (kutofautiana) vya vijidudu vya utumbo vililinganishwa kwa kutumia jaribio la Mann-Whitney U. Majaribio ya PERMANOVA yalifanywa kwa kutumia kazi ya adonis2 kutoka kwa pakiti ya R vegan na mabadiliko 1000. Uchambuzi uliundwa kwa majaribio mengi kwa kutumia mbinu ya Benjamini-Hochberg ili kudhibiti kiwango cha ugunduzi wa uongo kwa kiwango cha 10%. Urithi wa kimfumo uliamua kwa kutumia muundo wa ACE (kutoka kwa pakiti ya R mets). Muundo huu unahesabu ni kiasi gani cha mabadiliko ya kiphenotypic yanatokana na athari za kijeni zinazoongeza (A), mazingira ya pamoja (C) na mazingira ya kipekee kwa kila jamaa (E). Muundo huu ulipangwa kwa wingi wa vijidudu vilivyopatikana katika zaidi ya sampuli 2 katika kila mkono (
     <italic>
      wingi
     </italic>
     ∼ 1) na kutumika kuchora urithi wa kimfumo. Maelezo zaidi kuhusu uchanganuzi wa takwimu za vijidudu vya utumbo yanapatikana katika Kumbukumbu ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup>
      <xref ref-type="bibr" rid="CR89">
       89
      </xref>
      <xref ref-type="bibr" rid="CR90">
       90
      </xref>
      ,
      <xref ref-type="bibr" rid="CR91">
       91
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec24">
    <title>
     Ripoti ya maelezo
    </title>
    <p id="Par69">
     Maelezo zaidi kuhusu muundo wa utafiti yanapatikana katika
     <xref ref-type="supplementary-material" rid="MOESM3">
      Maelezo ya Kuripoti ya Nature Portfolio
     </xref>
     yaliyowekwa kwenye makala haya.
    </p>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    Shukrani
   </title>
   <p>
    Wandishi wanatamani kutoa shukrani kwa Taasisi ya Kitaifa ya Utafiti wa Afya kwa kuwafadhili katika utafiti huu. Pia tunatamani kutoa shukrani kwa wafanyakazi wa utafiti katika Idara ya Utafiti wa Watu Wanaofanana na washiriki wote. Hasa tunatamani kutoa shukrani kwa Deborah Hart, Ayrun Nessa, Alyce Sheedy, na Gulsah Akdag ambao walichangia kiasi kikubwa katika kufanya jaribio la PROMOTe. Tunashukuru Jopo la Ushauri la Kujitolea la TwinsUK kwa maoni yao ya kufikiria na maoni kuhusu muundo wa utafiti. Pia tunatamani kutoa shukrani kwa Roosa Varjus kwa kuchangia katika uchanganuzi wa microbiome. Utafiti huu ulihudhiwa pamoja na Chuo cha Kings London na Guy’s na St Thomas’ NHS Trust. Wala hakuna wa wadhifa hao walikuwa na jukumu lolote katika muundo wa utafiti, ukusanyaji wa data na uchanganuzi au uandishi wa makala. Ufadhili MNL anafadhiliwa na Ushirika wa Utafiti wa Taifa wa Afya (NIHR) (ufadhili wa nambari: NIHR300159). C.J.S. anapata fedha kutoka kwa Baraza la Utafiti wa Kimatibabu (MRC), Wellcome Trust (ufadhili wa nambari: WT 212904/Z/18/Z), na Taasisi ya Utafiti wa Magonjwa Sugu. K.W. amepata fedha kutoka kwa MRC, NIHR, Crohn’s na Colitis UK, Kenneth Rainin Foundation, Leona M. na Harry B. Helmsley Charitable Trust, Almond Board of California, Danone, na International Dried Fruit Council. TwinsUK inafadhiliwa na Wellcome Trust, Wellcome LEAP, MRC, Versus Arthritis, Engineering  Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, Tume ya Ulaya, Taasisi ya Utafiti wa Magonjwa Sugu (CDRF), Zoe Ltd., Taasisi ya Kitaifa ya Utafiti wa Afya na Huduma ya Afya (NIHR) Clinical Research Network (CRN) na Kituo cha Utafiti wa Kibiolojia kilichoko Guy’s na St Thomas’ NHS Foundation Trust kwa ushirikiano na Chuo cha Kings London. Programu ya kuripoti ya lishe ya myfood24 ilitumika katika utafiti huu. myfood24 ilibuniwa kupitia ufadhili wa MRC, ufadhili wa nambari G110235. myfood24 sasa inafadhiliwa na kampuni ya spinout ya Dietary Assessment Ltd. Ombi za kutumia myfood24 zinapaswa kufanywa kwa
    <email>
     enquiries@myfood24.org
    </email>
    .
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    Michango ya waandishi
   </title>
   <p>
    M.N.L., K.W. na C.J.S. walibuni utafiti na kuandika kifungu cha utafiti na ushauri kutoka kwa R.C.E.B., M.P.G, S.W., A.F.B, A.N., A.S., G.A., D.H., C.M., S.D.R.H., A.A.W. na C.G., A.N., A.S., G.A., D.H. na C.M. walisaidia jaribio la kimatibabu, ikijumuisha kuajiri na/au usimamizi wa wagonjwa katika jaribio. M.N.L. alifanya uchanganuzi wa takwimu na ushauri kutoka kwa C.J.S, K.W. R.C.E.B, P.T.S. na G.R. J.M.M. alifanya uchanganuzi wa microbiome na ushauri kutoka kwa M.N.L., C.J.S. na R.C.E.B. M.N.L., S.W., A.F.B, A.N. na A.S. walichangia kukusanya data na sampuli. M.N.L. aliandika makala. Waandishi wote walithauri makala na kuidhinisha toleo la mwisho.
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    Ukaguzi wa kielimu
   </title>
   <sec id="FPar1">
    <title>
     Maelezo ya ukaguzi wa kielimu
    </title>
    <p id="Par70">
     <italic>
      Nature Communications
     </italic>
     thanks Edward Chambers, Ali Keshavarzian and Huang Lin for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa data
   </title>
   <p>
    The gut microbiome sequencing data generated in this study have been deposited in the European Nucleotide Archive (ENA) at EMBL-EBI under accession number
    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB72531">
     PRJEB72531
    </ext-link>
    . All other data are available on request from TwinsUK, and access can be obtained after approval by the TwinsUK Resource Executive Committee by following this link:
    <ext-link ext-link-type="uri" xlink:href="https://twinsuk.ac.uk/resources-for-researchers/access-our-data/">
     https://twinsuk.ac.uk/resources-for-researchers/access-our-data/
    </ext-link>
    .
   </p>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa programu
   </title>
   <p>
    Stata code was utilised for data cleaning and analysis using Stata SE version 15.1
    <sup>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    . Gut microbiome analysis utilised R version 4.2.1
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
    </sup>
    , using R packages vegan (available from:
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/vegan/index.html">
     https://cran.r-project.org/web/packages/vegan/index.html
    </ext-link>
    ) and Mets (available from
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/mets/index.html">
     https://cran.r-project.org/web/packages/mets/index.html
    </ext-link>
    ).
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     Mashindano ya maslahi
    </title>
    <p id="Par71">
     C.J.S. has consulted for Zoe Limited for work on the Zoe Health Study. Janne Marie Moll is an employee of Clinical Microbiomics. K.W. is a co-inventor/patent holder for volatile organic compounds in the diagnosis and management of irritable bowel syndrome. The remaining authors declare no competing interests.
    </p>
   </sec>
   <sec id="FPar3">
    <title>
     Idhini ya kimaadili
    </title>
    <p id="Par72">
     The PROMOTe Study was approved by NHS North of Scotland Research Ethics Service (REC reference 21/NS/0045), IRAS ID 257415. This study was carried out under TwinsUK BioBank ethics, approved by North West—Liverpool Central Research Ethics Committee (REC reference 19/NW/0187), IRAS ID 258513. This approval supersedes earlier approvals granted to TwinsUK by the St Thomas’ Hospital Research Ethics Committee, later London—Westminster Research Ethics Committee (REC reference EC04/015), which have now been subsumed within the TwinsUK BioBank. Written informed consent was obtained from all participants. All research, therefore carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    Marudio
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kingston
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2017
      </year>
      <volume>
       390
      </volume>
      <fpage>
       1676
      </fpage>
      <lpage>
       1684
      </lpage>
      <pub-id pub-id-type="pmid">
       28821408
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5640505
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(17)31575-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arvanitakis
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <name>
        <surname>
         Shah
        </surname>
        <given-names>
         RC
        </given-names>
       </name>
       <name>
        <surname>
         Bennett
        </surname>
        <given-names>
         DA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Diagnosis and management of dementia: review
      </article-title>
      <source>
       J. Am. Med. Assoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       322
      </volume>
      <fpage>
       1589
      </fpage>
      <pub-id pub-id-type="doi">
       10.1001/jama.2019.4782
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harada
        </surname>
        <given-names>
         CN
        </given-names>
       </name>
       <name>
        <surname>
         Natelson Love
        </surname>
        <given-names>
         MC
        </given-names>
       </name>
       <name>
        <surname>
         Triebel
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Normal cognitive aging
      </article-title>
      <source>
       Clin. Geriatr. Med.
      </source>
      <year>
       2013
      </year>
      <volume>
       29
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       752
      </lpage>
      <pub-id pub-id-type="pmid">
       24094294
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4015335
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cger.2013.07.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sayer
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia definition, diagnosis and treatment: consensus is growing
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2022
      </year>
      <volume>
       51
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afac220
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mandolesi
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits
      </article-title>
      <source>
       Front. Psychol.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       509
      </fpage>
      <pub-id pub-id-type="pmid">
       29755380
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5934999
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fpsyg.2018.00509
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bowyer
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Steves
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Dietary protein and muscle in aging people: the potential role of the gut microbiome
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2018
      </year>
      <volume>
       10
      </volume>
      <fpage>
       929
      </fpage>
      <pub-id pub-id-type="pmid">
       30036990
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6073774
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu10070929
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Welch
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Nutritional influences on age-related skeletal muscle loss
      </article-title>
      <source>
       Proc. Nutr. Soc.
      </source>
      <year>
       2014
      </year>
      <volume>
       73
      </volume>
      <fpage>
       16
      </fpage>
      <lpage>
       33
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFylsL4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24229650
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0029665113003698
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Deutz
        </surname>
        <given-names>
         NEP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
      </article-title>
      <source>
       Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       33
      </volume>
      <fpage>
       929
      </fpage>
      <lpage>
       936
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXnslehtL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24814383
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4208946
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.clnu.2014.04.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cermak
        </surname>
        <given-names>
         NM
        </given-names>
       </name>
       <name>
        <surname>
         Res
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         de Groot
        </surname>
        <given-names>
         LC
        </given-names>
       </name>
       <name>
        <surname>
         Saris
        </surname>
        <given-names>
         WHM
        </given-names>
       </name>
       <name>
        <surname>
         van Loon
        </surname>
        <given-names>
         LJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2012
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1454
      </fpage>
      <lpage>
       1464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhslylsbfF
      </pub-id>
      <pub-id pub-id-type="pmid">
       23134885
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.112.037556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does lean red meat enhance the effetcs of exercise on muscle health and function in the elderly?
       <italic>
        Innov
       </italic>
      </article-title>
      <source>
       Aging
      </source>
      <year>
       2017
      </year>
      <volume>
       1
      </volume>
      <fpage>
       3
      </fpage>
      <lpage>
       4
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       99
      </volume>
      <fpage>
       899
      </fpage>
      <lpage>
       910
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXls1Oiur0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24477043
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.113.064154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Marchesi
        </surname>
        <given-names>
         JR
        </given-names>
       </name>
       <name>
        <surname>
         Ravel
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The vocabulary of microbiome research: a proposal
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2015
      </year>
      <volume>
       3
      </volume>
      <pub-id pub-id-type="pmid">
       26229597
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4520061
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-015-0094-5
      </pub-id>
      <elocation-id>
       31
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Biagi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2010
      </year>
      <volume>
       5
      </volume>
      <fpage>
       e10667
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2010PLoSO...510667B
      </pub-id>
      <pub-id pub-id-type="pmid">
       20498852
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2871786
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0010667
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grosicki
        </surname>
        <given-names>
         GJ
        </given-names>
       </name>
       <name>
        <surname>
         Fielding
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Lustgarten
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis
      </article-title>
      <source>
       Calcif. Tissue Int.
      </source>
      <year>
       2018
      </year>
      <volume>
       102
      </volume>
      <fpage>
       433
      </fpage>
      <lpage>
       442
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhslWjurrJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       29058056
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00223-017-0345-5
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2017
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1303
      </fpage>
      <pub-id pub-id-type="pmid">
       29189738
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5748753
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu9121303
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2017
      </year>
      <volume>
       7
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2017NatSR...711102T
      </pub-id>
      <pub-id pub-id-type="pmid">
       28894183
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5593887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-017-10734-y
      </pub-id>
      <elocation-id>
       11102
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ridaura
        </surname>
        <given-names>
         VK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota from twins discordant for obesity modulate metabolism in mice
      </article-title>
      <source>
       Science (1979)
      </source>
      <year>
       2013
      </year>
      <volume>
       341
      </volume>
      <fpage>
       1241214
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Prokopidis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Chambers
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Witard
        </surname>
        <given-names>
         OC
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1910
      </fpage>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2021.770455
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Raj
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Dileep
        </surname>
        <given-names>
         U
        </given-names>
       </name>
       <name>
        <surname>
         Vaz
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Fuller
        </surname>
        <given-names>
         MF
        </given-names>
       </name>
       <name>
        <surname>
         Kurpad
        </surname>
        <given-names>
         AV
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Intestinal microbial contribution to metabolic leucine input in adult men
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       138
      </volume>
      <fpage>
       2217
      </fpage>
      <lpage>
       2221
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXht1ymtr7J
      </pub-id>
      <pub-id pub-id-type="pmid">
       18936222
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/jn.108.093021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhang
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Cheng
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <name>
        <surname>
         Hu
        </surname>
        <given-names>
         YM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota as a promising therapeutic target for age-related sarcopenia
      </article-title>
      <source>
       Ageing Res. Rev.
      </source>
      <year>
       2022
      </year>
      <volume>
       81
      </volume>
      <fpage>
       101739
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xis1aisr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       36182084
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.arr.2022.101739
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         de Marco Castro
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Murphy
        </surname>
        <given-names>
         CH
        </given-names>
       </name>
       <name>
        <surname>
         Roche
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Targeting the gut microbiota to improve dietary protein efficacy to mitigate sarcopenia
      </article-title>
      <source>
       Front. Nutr.
      </source>
      <year>
       2021
      </year>
      <volume>
       8
      </volume>
      <fpage>
       656730
      </fpage>
      <pub-id pub-id-type="pmid">
       34235167
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8256992
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fnut.2021.656730
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lahiri
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The gut microbiota influences skeletal muscle mass and function in mice
      </article-title>
      <source>
       Sci. Transl. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       11
      </volume>
      <fpage>
       eaan5662
      </fpage>
      <pub-id pub-id-type="pmid">
       31341063
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7501733
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/scitranslmed.aan5662
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Manickam
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Oh
        </surname>
        <given-names>
         HYP
        </given-names>
       </name>
       <name>
        <surname>
         Tan
        </surname>
        <given-names>
         CK
        </given-names>
       </name>
       <name>
        <surname>
         Paramalingam
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Wahli
        </surname>
        <given-names>
         W
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2018
      </year>
      <volume>
       19
      </volume>
      <fpage>
       2418
      </fpage>
      <pub-id pub-id-type="pmid">
       30115857
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6121908
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms19082418
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus statement on the definition and scope of prebiotics
      </article-title>
      <source>
       Nat. Rev. Gastroenterol. Hepatol.
      </source>
      <year>
       2017
      </year>
      <volume>
       14
      </volume>
      <fpage>
       491
      </fpage>
      <lpage>
       502
      </lpage>
      <pub-id pub-id-type="pmid">
       28611480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrgastro.2017.75
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Buigues
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2016
      </year>
      <volume>
       17
      </volume>
      <fpage>
       932
      </fpage>
      <pub-id pub-id-type="pmid">
       27314331
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4926465
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms17060932
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Theou
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Can a prebiotic formulation reduce frailty levels in older people?
      </article-title>
      <source>
       J. Frailty Aging
      </source>
      <year>
       2018
      </year>
      <volume>
       8
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Desmedt
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of prebiotics on affect and cognition in human intervention studies
      </article-title>
      <source>
       Nutr. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       77
      </volume>
      <fpage>
       81
      </fpage>
      <lpage>
       95
      </lpage>
      <pub-id pub-id-type="pmid">
       30535275
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nutrit/nuy052
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cox
        </surname>
        <given-names>
         NJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The composition of the gut microbiome differs among community dwelling older people with good and poor appetite
      </article-title>
      <source>
       J. Cachexia Sarcopenia Muscle
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       368
      </fpage>
      <lpage>
       377
      </lpage>
      <pub-id pub-id-type="pmid">
       33580637
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8061352
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jcsm.12683
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guess
        </surname>
        <given-names>
         ND
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes
      </article-title>
      <source>
       Nutr. Metab. (Lond.)
      </source>
      <year>
       2015
      </year>
      <volume>
       12
      </volume>
      <fpage>
       36
      </fpage>
      <pub-id pub-id-type="pmid">
       26500686
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12986-015-0033-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Liber
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Szajewska
        </surname>
        <given-names>
         H
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials
      </article-title>
      <source>
       Ann. Nutr. Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       63
      </volume>
      <fpage>
       42
      </fpage>
      <lpage>
       54
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsF2rsL7L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23887189
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1159/000350312
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Baker
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults
      </article-title>
      <source>
       Neuropsychology
      </source>
      <year>
       2019
      </year>
      <volume>
       33
      </volume>
      <fpage>
       964
      </fpage>
      <lpage>
       974
      </lpage>
      <pub-id pub-id-type="pmid">
       31368758
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1037/neu0000561
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hicks
        </surname>
        <given-names>
         EB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s Dementia
      </article-title>
      <source>
       Int. Psychogeriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1135
      </fpage>
      <lpage>
       1144
      </lpage>
      <pub-id pub-id-type="pmid">
       33336635
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S1041610220003841
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Vulevic
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Drakoularakou
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Yaqoob
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Tzortzis
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       88
      </volume>
      <fpage>
       1438
      </fpage>
      <lpage>
       1484
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXhtlOqu7vP
      </pub-id>
      <pub-id pub-id-type="pmid">
       18996881
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.2008.26242
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bergquist
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Performance-based clinical tests of balance and muscle strength used in young seniors: a systematic literature review
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2019
      </year>
      <volume>
       19
      </volume>
      <fpage>
       9
      </fpage>
      <pub-id pub-id-type="pmid">
       30626340
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6327480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-018-1011-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harvey
        </surname>
        <given-names>
         NC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, Falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study
      </article-title>
      <source>
       J. Bone Miner. Res.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id pub-id-type="pmid">
       30011086
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jbmr.3556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         SN
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maintenance of activity and eating change after a clinical trial of tailored newsletters with older rural women
      </article-title>
      <source>
       Nurs. Res.
      </source>
      <year>
       2010
      </year>
      <volume>
       59
      </volume>
      <fpage>
       311
      </fpage>
      <lpage>
       321
      </lpage>
      <pub-id pub-id-type="pmid">
       20697307
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2963620
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/NNR.0b013e3181ed6695
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cesari
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Added value of physical performance measures in predicting adverse health-related events: results from the health, aging, and body composition study
      </article-title>
      <source>
       J. Am. Geriatr. Soc.
      </source>
      <year>
       2009
      </year>
      <volume>
       57
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19207142
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2695653
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1532-5415.2008.02126.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tandon
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019NatSR...9.5473T
      </pub-id>
      <pub-id pub-id-type="pmid">
       30940833
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6445088
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-019-41837-3
      </pub-id>
      <elocation-id>
       5473
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         So
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       107
      </volume>
      <fpage>
       965
      </fpage>
      <lpage>
       983
      </lpage>
      <pub-id pub-id-type="pmid">
       29757343
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy041
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="other">
      Cognitive Tests | Cambridge Cognition.
      <ext-link ext-link-type="uri" xlink:href="https://www.cambridgecognition.com/cantab/cognitive-tests/">
       https://www.cambridgecognition.com/cantab/cognitive-tests/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The microbiota-gut-brain axis
      </article-title>
      <source>
       Physiol. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       99
      </volume>
      <fpage>
       1877
      </fpage>
      <lpage>
       2013
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitFWjsLs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       31460832
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/physrev.00018.2018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jenkins
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Nguyen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Polglaze
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Bertrand
        </surname>
        <given-names>
         P
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2016
      </year>
      <volume>
       8
      </volume>
      <fpage>
       56
      </fpage>
      <pub-id pub-id-type="pmid">
       26805875
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4728667
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu8010056
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grenham
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Clarke
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <name>
        <surname>
         Dinan
        </surname>
        <given-names>
         TG
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Brain-gut-microbe communication in health and disease
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2011
      </year>
      <volume>
       2
      </volume>
      <fpage>
       94
      </fpage>
      <pub-id pub-id-type="pmid">
       22162969
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3232439
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2011.00094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gaman
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Kuo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Neuromodulatory processes of the brain–gut axis
      </article-title>
      <source>
       Neuromodulation
      </source>
      <year>
       2008
      </year>
      <volume>
       11
      </volume>
      <fpage>
       249
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19844605
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2763396
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1525-1403.2008.00172.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tran
        </surname>
        <given-names>
         TTT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2019
      </year>
      <volume>
       7
      </volume>
      <pub-id pub-id-type="pmid">
       30867067
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6417215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-019-0654-1
      </pub-id>
      <elocation-id>
       39
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lancaster
        </surname>
        <given-names>
         SM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2022
      </year>
      <volume>
       30
      </volume>
      <fpage>
       848
      </fpage>
      <lpage>
       862.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XhtFejtbvE
      </pub-id>
      <pub-id pub-id-type="pmid">
       35483363
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9187607
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2022.03.036
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Healey
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study
      </article-title>
      <source>
       Br. J. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       119
      </volume>
      <fpage>
       176
      </fpage>
      <lpage>
       189
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhsVarsrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29307330
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0007114517003440
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Le Bastard
        </surname>
        <given-names>
         Q
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of inulin on gut microbial composition: a systematic review of evidence from human studies
      </article-title>
      <source>
       Eur. J. Clin. Microbiol. Infect. Dis.
      </source>
      <year>
       2020
      </year>
      <volume>
       39
      </volume>
      <fpage>
       403
      </fpage>
      <lpage>
       413
      </lpage>
      <pub-id pub-id-type="pmid">
       31707507
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10096-019-03721-w
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Watson
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Selective carbohydrate utilization by lactobacilli and bifidobacteria
      </article-title>
      <source>
       J. Appl. Microbiol.
      </source>
      <year>
       2013
      </year>
      <volume>
       114
      </volume>
      <fpage>
       1132
      </fpage>
      <lpage>
       1146
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXkt1Kiu7o%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23240984
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/jam.12105
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wilson
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Rossi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Dimidi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Whelan
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2019
      </year>
      <volume>
       109
      </volume>
      <fpage>
       1098
      </fpage>
      <lpage>
       1111
      </lpage>
      <pub-id pub-id-type="pmid">
       30949662
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cherbut
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Michel
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Lecannu
        </surname>
        <given-names>
         G
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2003
      </year>
      <volume>
       133
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3sXjslejtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       12514261
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/jn/133.1.21
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic determinants of the gut microbiome in UK twins
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2016
      </year>
      <volume>
       19
      </volume>
      <fpage>
       731
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XntlShtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27173935
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4915943
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2016.04.017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Human genetics shape the gut microbiome
      </article-title>
      <source>
       Cell
      </source>
      <year>
       2014
      </year>
      <volume>
       159
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       799
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhvV2msrnJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25417156
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4255478
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cell.2014.09.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
      </article-title>
      <source>
       Gut
      </source>
      <year>
       2022
      </year>
      <volume>
       71
      </volume>
      <fpage>
       2451
      </fpage>
      <lpage>
       2462
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XivFegtb3P
      </pub-id>
      <pub-id pub-id-type="pmid">
       35387876
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/gutjnl-2021-326482
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Xie
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome
      </article-title>
      <source>
       Cell Syst.
      </source>
      <year>
       2016
      </year>
      <volume>
       3
      </volume>
      <fpage>
       572
      </fpage>
      <lpage>
       584.e3
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtFalsLw%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27818083
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6309625
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cels.2016.10.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stincone
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
      </article-title>
      <source>
       Biol. Rev.
      </source>
      <year>
       2015
      </year>
      <volume>
       90
      </volume>
      <fpage>
       927
      </fpage>
      <lpage>
       963
      </lpage>
      <pub-id pub-id-type="pmid">
       25243985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/brv.12140
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wagner
        </surname>
        <given-names>
         KR
        </given-names>
       </name>
       <name>
        <surname>
         Kauffman
        </surname>
        <given-names>
         FC
        </given-names>
       </name>
       <name>
        <surname>
         Max
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The pentose phosphate pathway in regenerating skeletal muscle
      </article-title>
      <source>
       Biochem. J.
      </source>
      <year>
       1978
      </year>
      <volume>
       170
      </volume>
      <fpage>
       17
      </fpage>
      <lpage>
       22
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaE1cXhsV2ks7Y%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       629775
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1183856
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1042/bj1700017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valentino
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Figueiredo
        </surname>
        <given-names>
         VC
        </given-names>
       </name>
       <name>
        <surname>
         Mobley
        </surname>
        <given-names>
         CB
        </given-names>
       </name>
       <name>
        <surname>
         McCarthy
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Vechetti
        </surname>
        <given-names>
         IJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy
      </article-title>
      <source>
       Physiol. Rep.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       15137
      </fpage>
      <pub-id pub-id-type="doi">
       10.14814/phy2.15137
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carabotti
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Scirocco
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Maselli
        </surname>
        <given-names>
         MA
        </given-names>
       </name>
       <name>
        <surname>
         Severi
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
      </article-title>
      <source>
       Ann. Gastroenterol.
      </source>
      <year>
       2015
      </year>
      <volume>
       28
      </volume>
      <fpage>
       203
      </fpage>
      <pub-id pub-id-type="pmid">
       25830558
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4367209
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Connell
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
      </article-title>
      <source>
       Mol. Neurodegener.
      </source>
      <year>
       2022
      </year>
      <volume>
       17
      </volume>
      <fpage>
       43
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XitVeqt7bF
      </pub-id>
      <pub-id pub-id-type="pmid">
       35715821
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9204954
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13024-022-00548-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jeong
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cognitive function associated with gut microbial abundance in sucrose and S-adenosyl-L-methionine (SAMe) metabolic pathways
      </article-title>
      <source>
       J. Alzheimer’s Dis.
      </source>
      <year>
       2022
      </year>
      <volume>
       87
      </volume>
      <fpage>
       1115
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xhtl2lurvK
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3233/JAD-215090
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson’s disease
      </article-title>
      <source>
       Front. Immunol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       2541
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fernandez-Real
        </surname>
        <given-names>
         J-M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota interacts with brain microstructure and function
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2015
      </year>
      <volume>
       100
      </volume>
      <fpage>
       4505
      </fpage>
      <lpage>
       4513
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XjtlSntr0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       26445114
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2015-3076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tooley
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2020
      </year>
      <volume>
       12
      </volume>
      <fpage>
       3009
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitlyjur3K
      </pub-id>
      <pub-id pub-id-type="pmid">
       33007941
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7601389
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu12103009
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Witham
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2020
      </year>
      <volume>
       21
      </volume>
      <pub-id pub-id-type="pmid">
       32738919
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7395975
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-020-04613-7
      </pub-id>
      <elocation-id>
       694
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodwin
        </surname>
        <given-names>
         VA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       INCLUDE older people: best practice recommendations in health and social care research
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2023
      </year>
      <volume>
       52
      </volume>
      <fpage>
       afad082
      </fpage>
      <pub-id pub-id-type="pmid">
       37261448
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10234283
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afad082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         AJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia: revised European consensus on definition and diagnosis
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2019
      </year>
      <volume>
       48
      </volume>
      <fpage>
       601
      </fpage>
      <lpage>
       601
      </lpage>
      <pub-id pub-id-type="pmid">
       31081853
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6593317
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afz046
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="other">
      Verdi, S. et al. TwinsUK: The UK Adult Twin Registry Update.
      <italic>
       Twin Res. Hum. Genetics
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1017/thg.2019.65">
       https://doi.org/10.1017/thg.2019.65
      </ext-link>
      (2019).
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       21
      </volume>
      <fpage>
       407
      </fpage>
      <pub-id pub-id-type="pmid">
       34210274
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8248289
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-021-02301-y
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Masoli
        </surname>
        <given-names>
         JAH
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2021
      </year>
      <volume>
       22
      </volume>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXislajt73K
      </pub-id>
      <pub-id pub-id-type="pmid">
       34895305
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8665850
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-021-05880-8
      </pub-id>
      <elocation-id>
       911
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Office for National Statistics. Internet users UK 2020.
      <ext-link ext-link-type="uri" xlink:href="https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020">
       https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="other">
      Doody, P. et al.
      <italic>
       Internet access and use among adults aged 50 and over in Ireland: Results from Wave 5 of The Irish Longitudinal Study on Ageing
      </italic>
      .
      <italic>
       The Irish Longitudinal Study on Ageing
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.38018/TildaRe.2020-06">
       https://doi.org/10.38018/TildaRe.2020-06
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carter
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Development of a UK Online 24-h Dietary Assessment Tool: myfood24
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2015
      </year>
      <volume>
       7
      </volume>
      <fpage>
       4016
      </fpage>
      <lpage>
       4032
      </lpage>
      <pub-id pub-id-type="pmid">
       26024292
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4488770
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu7064016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Threapleton
        </surname>
        <given-names>
         DE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Usability of myfood24 healthcare and mathematical diet optimisation in clinical populations: a pilot feasibility randomised controlled trial
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2022
      </year>
      <volume>
       14
      </volume>
      <fpage>
       1768
      </fpage>
      <pub-id pub-id-type="pmid">
       35565736
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9101756
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu14091768
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="other">
      Strength exercises—NHS.
      <ext-link ext-link-type="uri" xlink:href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
       https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Millor
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Lecumberri
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Gómez
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Martínez-Ramírez
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Izquierdo
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       An evaluation of the 30-s chair stand test in older adults: frailty detection based on kinematic parameters from a single inertial unit
      </article-title>
      <source>
       J. Neuroeng. Rehabil.
      </source>
      <year>
       2013
      </year>
      <volume>
       10
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       9
      </lpage>
      <pub-id pub-id-type="doi">
       10.1186/1743-0003-10-86
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="other">
      Dodds, R. M. et al. Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia.
      <italic>
       J. Cachexia Sarcopenia Muscle
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1002/jcsm.12660">
       https://doi.org/10.1002/jcsm.12660
      </ext-link>
      (2021).
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Durbin
        </surname>
        <given-names>
         R
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Fast and accurate short read alignment with Burrows–Wheeler transform
      </article-title>
      <source>
       Bioinformatics
      </source>
      <year>
       2009
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1754
      </fpage>
      <lpage>
       1760
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXot1Cjtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       19451168
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2705234
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/bioinformatics/btp324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Huerta-Cepas
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Fast genome-wide functional annotation through orthology assignment by eggNOG-Mapper
      </article-title>
      <source>
       Mol. Biol. Evol.
      </source>
      <year>
       2017
      </year>
      <volume>
       34
      </volume>
      <fpage>
       2115
      </fpage>
      <lpage>
       2122
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhvFaru7vF
      </pub-id>
      <pub-id pub-id-type="pmid">
       28460117
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5850834
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molbev/msx148
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kanehisa
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       KEGG: Kyoto Encyclopedia of Genes and Genomes
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2000
      </year>
      <volume>
       28
      </volume>
      <fpage>
       27
      </fpage>
      <lpage>
       30
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3cXhvVGqu74%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10592173
      </pub-id>
      <pub-id pub-id-type="pmcid">
       102409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nar/28.1.27
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kim
        </surname>
        <given-names>
         B-R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Deciphering diversity indices for a better understanding of microbial communities
      </article-title>
      <source>
       J. Microbiol Biotechnol.
      </source>
      <year>
       2017
      </year>
      <volume>
       27
      </volume>
      <fpage>
       2089
      </fpage>
      <lpage>
       2093
      </lpage>
      <pub-id pub-id-type="pmid">
       29032640
      </pub-id>
      <pub-id pub-id-type="doi">
       10.4014/jmb.1709.09027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gacesa
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Environmental factors shaping the gut microbiome in a Dutch population
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2022
      </year>
      <volume>
       604
      </volume>
      <fpage>
       732
      </fpage>
      <lpage>
       739
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022Natur.604..732G
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XpvV2iu7k%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35418674
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41586-022-04567-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sahu
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Prasuna
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Twin studies: a unique epidemiological tool
      </article-title>
      <source>
       Indian J. Commun. Med.
      </source>
      <year>
       2016
      </year>
      <volume>
       41
      </volume>
      <fpage>
       177
      </fpage>
      <pub-id pub-id-type="doi">
       10.4103/0970-0218.183593
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="other">
      StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. (2019).
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="other">
      RStudio Team &amp; RStudio: Integrated Development for R.
      <italic>
       RStudio
      </italic>
      . (RStudio, Inc., Boston, MA, 2015).
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity
      </article-title>
      <source>
       Eur. J. Clin. Nutr.
      </source>
      <year>
       2000
      </year>
      <volume>
       54
      </volume>
      <fpage>
       395
      </fpage>
      <lpage>
       404
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3c3osVWjuw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10822286
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ejcn.1600971
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations
      </article-title>
      <source>
       Int. J. Obes.
      </source>
      <year>
       2000
      </year>
      <volume>
       24
      </volume>
      <fpage>
       1119
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3cvosFehsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ijo.0801376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <collab>
        Dietary reference values for food energy and nutrients for the United Kingdom.
       </collab>
      </person-group>
      <article-title xml:lang="en">
       Report of the panel on dietary reference values of the committee on medical aspects of food policy
      </article-title>
      <source>
       Rep. Health Soc. Subj. (Lond.)
      </source>
      <year>
       1991
      </year>
      <volume>
       41
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       210
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="other">
      Oksanen, J. et al. vegan: Community Ecology Package [R package version 2.6-4].
      <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=vegan">
       https://cran.r-project.org/package=vegan
      </ext-link>
      (2022).
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The liability threshold model for censored twin data
      </article-title>
      <source>
       Comput. Stat. Data Anal.
      </source>
      <year>
       2016
      </year>
      <volume>
       93
      </volume>
      <fpage>
       324
      </fpage>
      <lpage>
       335
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3406215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.csda.2015.01.014
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Estimating heritability for cause specific mortality based on twin studies
      </article-title>
      <source>
       Lifetime Data Anal.
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       210
      </fpage>
      <lpage>
       233
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3181012
      </pub-id>
      <pub-id pub-id-type="pmid">
       23378036
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10985-013-9244-x
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec25">
     <title>
      Maelezo ya ziada
     </title>
     <p id="Par73">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title>
    Maelezo ya ziada
   </title>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-46116-y">
     https://doi.org/10.1038/s41467-024-46116-y
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
